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ABSTRACT 
 
 
 
 
 
 
 
Early B-cell factor 2 (Ebf2) is one of four mammalian members of the helix-loop-
helix transcription factor family Collier/Olf/Ebf (COE). COE proteins EBF1, EBF2 
and EBF3 have been implicated in various aspects of neural development including 
neurogenesis, cell differentiation, neuronal migration and axonal fasciculation. Here, 
I examined the role of one of these proteins, EBF2, on the development of the 
cerebral cortex. 
Ebf2 mRNA, detected by in situ hybridisation, was transiently expressed in the 
developing mouse cerebral cortex. In particular, it was found in the cortical hem, 
septum and preplate/marginal zone, which are known sites of origin and migration 
for Cajal-Retzius cells, respectively. In order to permanently label Ebf2 positive cells 
even after the downregulation of the gene expression, the transgenic line Ebf2GFPiCre 
was crossed with the reporter line Rosa26RYFP. It was found that the expression of 
Ebf2 matched the expression of markers for Cajal-Retzius cells, subplate cells and a 
subpopulation of layer V pyramidal neurons. Although Ebf2-/- mice showed a delay 
in the migration of Cajal-Retzius cells at early stages of development, which was 
rescued by the end of gestation, they did not present any other gross defect in cortical 
topography and cellular organisation. In vivo and in vitro studies have suggested that 
Ebf1 and Ebf3, also expressed in the cortical hem and septum, may be involved in 
complementing the lack of Ebf2 function. These results suggest a role for the EBF 
family in controlling Cajal-Retzius cell development. 
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Sp8  Zinc finger transcription factor 
St  Striatum 
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SVZ  Subventricular zone 
Tbr  T-Box brain gene 
TCA  Thalamo-cortical axon 
TE  Thalamic eminences 
TGF  Transforming growth factor 
Th  Thalamus 
v  Ventral 
Vax  Ventral anterior homeobox containing gene 
Vldlr  Very low density lipoprotein receptor 
VZ  Ventricular zone 
WNT  Wingless gene 
wt  Wild type 
Zi  Zona incerta 
Zic  Zinc finger transcription factor 
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Above all do not fear difficult moments, the best comes from them. (Rita Levi Montalcini) 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CHAPTER 1 
STRUCTURE AND GENETIC REGULATION OF 
THE DEVELOPMENT OF THE CEREBRAL 
CORTEX 
 
 
 
 
 
 
The nature, structure, and regulation of genes have been a central topic of interest 
for more than 100 years. However, early theories of heredity, even without any 
scientific support, can be found as early as in Greek philosophers’, such as 
Hippocrates and Aristotle, doctrines. Aristotle's major biological works formulated in 
On the Generation of Animals raises the fundamental questions about reproduction, 
development, and heredity. In attempting to explain how animals produce offspring 
like themselves, Aristotle examined two major models of development known as 
preformation and epigenesis. Preformationist theories hold that a miniature 
individual pre-exists in either the egg or the semen and begins to grow into its adult 
form when properly stimulated. The theory of epigenesis, which Aristotle favoured, 
asserts that the new organism is gradually produced from an undifferentiated mass by 
the addition of parts. Artistotle's theories formed the core of biological thought for 
hundreds of years.  
The history of modern genetics is generally thought to have started with the work 
of the Augustinian friar, Gregor Mendel. It was his work on pea plants, published in 
1866, that described for the first time what is now widely known as the Mendelian 
inheritance theory. Wilhelm Johannsen, however, only coined the name “gene” in 
1909. Later, the work on Drosophila of Thomas Hunt Morgan and his colleagues 
established that genes were located on chromosomes and, in 1940; Oswald Avery 
demonstrated that genes were composed of deoxyribonucleic acid (DNA). It was 
only the discovery of the structure of DNA in 1953 by James Watson and Francis 
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Crick that set the beginning for years of research into gene function. Moreover, the 
generation of the first knockout mouse by Mario Capecchi, Martin Evans and Oliver 
Smithies, awarded the Nobel Prize in Medicine in 1989, and the various genome 
sequencing projects, made possible to study the effects of loss of genes and gain of 
function. This allowed medical and biological research to understand how genes 
influence the development and functions of different organs in model animals as well 
as in humans. Moreover, mutations of different genes have been now linked with 
different diseases.  
So far, many genes have been identified and studied for their roles in brain 
development, which is one of the most complex and finely regulated organs in the 
human body. However, the nature of thousands of genes expressed in the nervous 
system is still poorly understood prompting the efforts of many scientists to keep 
researching for new discoveries (Mayr, 1984). 
 
 
1.1. ADULT CEREBRAL CORTEX STRUCTURE 
 
The cerebral cortex is the most elaborate structure of the mammalian brain, and is 
related to the achievement of complex brain functions such as motor and sensory 
processing, and cognitive capabilities. Proper assembly of the cortex requires precise 
gene expression patterns and regulation of neuronal migration during its 
development. Disruptions of these processes lead to abnormalities that can result in 
severe neurological diseases.  
 
1.1.1 Organization of the adult cortex 
 
Phylogenetically, the cerebral cortex is subdivided in allocortex (evolutionary 
older region) and neocortex (or isocortex, evolutionary younger region). The 
allocortex is further subdivided in paleocortex and archicortex. The paleocortex gives 
rise to olfactory regions whereas the archicortex contains the hippocampus (Gotz, 
2001). 
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Mainly two types of neurons populate the adult cerebral neocortex: projection 
neurons, also called pyramidal cells, and interneurons. These cells are organised into 
six different layers consecutively arranged from the pial surface to the subcortical 
white matter (Kandel, 2000): I - molecular layer; II - external granular layer; III – 
external pyramidal layer; IV - internal granular layer; V - internal pyramidal layer; 
VI - multiform or fusiform layer (Figure 1.1). 
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Figure 1.1 Layer organisation in the adult cerebral cortex 
 
Roman numbers from I to VI indicate the different cortical layers. 
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(Modified from ‘The human body’, 2nd Ed Mosby, 1988) 
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1.1.2 Neuron populations 
 
Projection cells, called pyramidal neurons after their soma shape, are the most 
abundant population in the neocortex. Morphologically, they have a long apical 
dendrite that ascends vertically to reach the cortical surface and basal dendrites that 
are directed horizontally. Dendrites bear spines that are the sites of synaptic contacts. 
Pyramidal cells project a long axon towards different territories and, as such, they are 
the main output neurons of the cortex. They use the excitatory amino acid glutamate 
as neurotransmitter (Kandel, 2000). 
Interneurons or local circuit neurons are inhibitory in function; they use the 
neurotransmitter γ-amino-butyric acid (GABA). Interneurons represent 
approximately the 25% of the cortical neuronal population, and they are distributed 
in all six layers. Several types of interneurons have been described based on their 
pattern of connections and morphological appearance. It is possible to distinguish 
basket cells, chandelier cells, bipolar cells and stellate cells. Moreover, interneurons 
express different calcium binding proteins such as Calbindin (Calb), Calretinin (Calr) 
and Paravalbumin (Pv), as well as neuropeptides and enzymes. Interneurons make 
synapses with other interneurons and pyramidal cells, but their axons are distributed 
entirely within the cortex (Kandel, 2000). 
 
1.1.3 Connections 
 
Cortical afferents that arise from the thalamus, called thalamocortical axons, reach 
mainly layer IV as well as layers I, III and VI. Afferents from cortical neurons of the 
same or opposite hemisphere contact, instead, layers II and III. There are three 
different types of cortical efferents or corticofugal projections: corticothalamic fibers 
that reach the thalamus from layer VI, corticocortical from layers II and III and 
corticosubcortical from layer V. Corticocortical efferents are subdivided into 
controlateral fibers, which connect neurons in the two hemispheres (also called 
commissural fibers), and ipsilateral fibers, which connect areas in the same 
hemisphere. Corticosubcortical efferents connect the neocortex with the striatum, 
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superior collicus, pons and spinal cord (later known as corticospinal or pyramidal 
tract (Kandel, 2000). 
 
1.2  DEVELOPMENT OF THE EMBRYONIC CEREBRAL CORTEX  
 
The cerebral cortex is a very complex structure, composed by different areas, 
which have specialised functions such as sensory processing and motor control. The 
areal identity seems to be determined by mechanisms suggested by two hypotheses. 
On one hand, the protomap hypothesis (Rakic, 1988) is in favour of a genetic 
specification of cortical neurons in the proliferative zone at the time of birth. 
According to this model, the early neuroepithelium is programmed to generate 
specific cohorts of neurons in different cortical regions, and the relative positions and 
sizes of cortical areas are so pre-specified. In contrast, the protocortex model 
(O'Leary, 1989) supports the role of thalamo-cortical connections in specifying 
functional areas of the cortex (O'Leary et al. 1994). 
 
1.2.1 Regional organization 
 
In mammals, the central nervous system (CNS) arises from the neural plate. 
During neurulation, the neural plate folds to form the neural tube, which will 
differentiate into brain and spinal cord. At embryonic day 9.5 (E9.5) in the mouse, 
the anterior end of the neural tube expands unequally producing a series of swellings 
that will form the forebrain (prosencephalon), the midbrain (mesencephalon) and the 
hindbrain (rhombencephalon) regions. The forebrain contains the telencephalon and 
the diencephalon. The telencephalon is subdivided into a dorsal domain called the 
pallium and a ventral domain called the subpallium. The two primary structures of 
the pallium are the cerebral cortex and the hippocampus. The main subpallial 
structures are the basal ganglia and the entopeduncular/preoptic area (AEP/POA). 
The basal ganglia arise from two bulges surrounding the later ventricles, the medial 
ganglionic eminence (MGE or globus pallidus primordium) and the lateral 
ganglionic eminence (LGE or striatum primordium). A third eminence, called the 
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caudal ganglionic eminence (CGE), is thought to give rise to the amygdala (Gotz, 
2001) (Figure 1.2). 
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Figure 1.2 Anatomical organization of the developing forebrain.  
 
A: Schema of a sagittal section through the brain of an E12.5 mouse showing 
forebrain, diencephalon and telencephalon. The pallium is in light grey colour.  
B: Schema of a transverse section through the telencephalon of an E12.5 mouse 
indicating its main subdivisions.  
 
MGE: medial ganglionic eminence, LGE: lateral ganglionic eminence, POA: anterior 
preoptic area.  
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(Modified from Marin et al. 2003) 
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1.2.2 Laminar organization 
 
Cortical neurogenesis is characterised by generation of post-mitotic neurons that 
arise from the ventricular surface and settle beneath the pial surface. This event 
transforms the neuroepithelium in a layered structure composed at the beginning by 
the ventricular zone (VZ) and the preplate (PPL), which contains the first generated 
neurons. At E13.5, the PPL splits in two parts due to the arrival of the cortical plate 
(CP), the marginal zone (MZ) and the subplate (SP) (Marin-Padilla, 1978; 1988). 
The MZ, which will became layer I, is populated by Cajal Retzius (CR) cells and 
interneurons. The CP is populated by pyramidal cells, whereas the SP by subplate 
cells and interneurons. Birth-dating experiments have demonstrated that layers in the 
CP are formed in an “inside-out” manner. This means that layer VI neurons are born 
before those in layer V, and the last neurons to be generated are in layers II and III. 
Thus, later generated neurons migrate through the entire CP to reach and to settle at 
its surface (Gotz, 2001). A secondary germinal zone, called subventricular zone 
(SVZ), forms superficial to the VZ around E15.5. The intermediate zone (IZ), 
prospective white matter, appears early (E13.5), and contains fibers and migrating 
neurons. Neurogenesis of the neocortex is completed before birth in rodents. 
However, in the dentate gyrus (part of the hippocampus) and in the anterior SVZ, 
neurogenesis continues throughout life (Rakic, 1988; Gotz, 2001) (Figure 1.3). 
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Figure 1.3 Cortical layer development  
 
The development of the cerebral cortex is shown at different embryonic stages. 
 
CP: cortical plate, IZ: intermediate zone, MZ: marginal zone, PPL: preplate, SP: 
subplate, SVZ: subventricular zone, VZ: ventricular zone. 
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(Modified from Molnar et al. 2006) 
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1.2.3 Formation of cortico-thalamic connections and the function of 
subplate cells 
  
The pathfinding of thalamic axons towards the isocortex involves several phases. 
Thalamic axons first grow towards the cortex through the internal capsule, part of 
basal ganglia, and after their arrival in the cortex they extend tangentially along the 
IZ without entering the CP. This mechanism is regulated by the presence of growth 
promoting molecules, such as fibronectin, tenascin and proteoglycans, in the IZ and 
in the SP layer and of repulsive cues in the CP. This is necessary to avoid the arrival 
of thalamic axons in the cortex when the generation of their target cells in layer IV is 
not yet complete. In fact, prior to the establishment of neurons in layer IV, the 
thalamic fibers reside in the SP layer (Kanold et al. 2010; Wang et al. 2010). 
Subplate neurons play a key role in early cortical development in coordinating 
reciprocal thalamocortical innervation. Subplate cells at early developmental stages 
are found in the PPL. Following the splitting of this layer, these cells are localised in 
the SP layer (Konig et al. 1981). Subplate cells acquire a neuronal phenotype early 
during embryonic development, even before CP neurons (Clancy et al. 2001; Arias et 
al. 2002), including the formation of synaptic inputs and the generation of action 
potentials. These cells project axons into the internal capsule where they serve an 
important role in innervating the thalamus and providing a scaffold for the 
innervation of the cortex by the thalamocortical axons (Kanold et al. 2003). It has 
been shown that if the SP cells are lesioned during development, thalamic axons fail 
to reach their correct cortical targets (McConnell et al. 1994), and cortical columnar 
organisation does not develop normally (Kanold et al. 2003).  
After serving as transient innervation targets for thalamocortical axons, most of 
SP cells die, and layer IV neurons become innervated by thalamic axons. However, 
10-20% of these cells survive, remaining at the bottom of layer VI and in the white 
matter in adult life.  
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1.3  GENE EXPRESSION SPECIFIES TELENCEPHALIC 
DEVELOPMENT 
 
1.3.1 Patterning of the cerebral cortex at early developmental stages 
 
The onset of neurogenesis coincides with the appearance of patterning centers 
positioned at the perimeters of the telencephalon that generate across the developing 
cortex the graded expression of various transcription factors (TF) (for example 
COUP-TFI, EMX2, PAX6 and Sp8) that promote area specification. The two major 
dorsal telencephalic patterning centers are: the commissural plate (CoP) at the 
anterior margin of the forebrain, which expresses several members of the fibroblast 
growth factor family (FGFs, in particular Fgf8 and Fgf17), and the cortical hem (CH) 
at the posteromedial border, which expresses bone morphogenetic proteins (BMPs) 
and vertebrate orthologs of Drosophila Wingless (Wnts) genes (O'Leary et al. 2007).  
Moreover, two other additional patterning centers have been identified: the first, 
located in the ventral telencephalon, expresses Sonic hedgehog (Shh) and is 
implicated in the regional patterning of the diencephalon and, indirectly, in cortical 
arealisation (Grove et al. 1999). The second, the antihem, located in the lateral area 
of the GE, secretes the Wnt antagonist Secreted Frizzled Related Protein-2 (SFRP-2), 
FGF7, Epidermal Growth Factors (EGF) family members (such as Neuregulins 1,2, 
3) and Transforming Growth Factor-α (TGF-α) (Assimacopoulos et al. 2003). The 
CH and antihem have been suggested to cooperate with the CoP to establish the 
anterior-posterior and medial-lateral axes of the developing cortex. For example, 
ectopic expression of FGFs and SHH inhibit the expression of BMPs and WNTs 
(Shimogori et al. 2004).  
It has been shown that Fgf8, secreted by the CoP, promotes also the graded 
expression of Chick Ovalbumin Upstream Transcription Factor I (COUP-TFI) and 
Empty Spiracles homeobox 2 gene (Emx2). These factors are characterised by a low 
anterior and high posterior expression gradient. In utero electroporation experiments 
have shown that Fgf8, whose expression is initiated by Hox genes and maintained by 
Shh and zinc finger TF Sp8 (related to Buttonhead gene in Drosophila), controls the 
formation of motor areas in the anterior part of the telencephalon (Fukuchi-
Shimogori et al. 2001). It seems that Emx2 is able to repress Fgf8 by suppressing the 
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function of Sp8 (Sahara et al. 2007). In fact, in the absence of Emx2, Fgf8 shows 
extended expression to posterior domains (Rakic et al. 2009). Moreover, pallial 
neuroblasts in Emx2 mutants are converted into subpallial neuroblasts, which 
accumulate in an aberrant structure resembling the basal ganglia (Muzio et al. 2002). 
Analysis of the cerebral cortex has detected the expression of EMX2 not only in the 
VZ but, interestingly, also in CR cells (Mallamaci et al. 1998). Emx2 expression in 
the proliferative layer of the developing cerebral cortex and in the CR cells suggests 
a potential role for the gene in the control of neuronal proliferation, migration and 
differentiation processes. 
Furthermore, COUP-TFI is also involved in the specification of posterior 
telencephalic area together with Emx2. In fact, COUP-TFI null mice show lack of 
somatosensory areas and posterior expansion of anterior frontal and motor domains 
(Zhou et al. 2001). On the other hand, the CH (called roof plate together with the 
choroid plexus) is specified by LIM-homeodomain 5 gene (Lhx5). Loss of Lhx5 
expression leads to loss of choroid plexus, CH and a defective hippocampal 
formation (Sheng et al. 1997; Zhao et al. 1999). In contrast, the lack of Lhx2, which 
is expressed in the cortical VZ, allows the choroid plexus and CH to dramatically 
expand, whereas the neocortex is reduced in size (Bulchand et al. 2001). Moreover, 
in the absence of Forkhead box G1 (Foxg1), neocortical progenitors are not specified 
and progenitors of the hippocampus and CH, in particular the CR cell population, are 
expanded (Monuki et al. 2001).   
Other regulatory genes are also involved in the specification of the cortical areas; 
among these Paired box gene 6 (Pax6) plays multiple roles in the development of the 
cerebral cortex (Scardigli et al. 2003; Guillemot et al. 2006). Firstly, Pax6 is 
involved in the dorso-ventral specification of telencephalic progenitors and its 
expression is opposite to Emx2. In the cortical primordium, the early expression of 
Pax6 and the homeobox gene Gsh2 outline the anlage of the pallium and subpallium, 
respectively, and cross-repressive interactions between these two genes establish the 
pallial–subpallial border (PSPB) (Toresson et al. 2000; Yun et al. 2001). Disruption 
of the PSPB in the Pax6–Small eye mutant, where Pax6 is not expressed, leads to an 
expansion of subpallial markers such as Dlx1, Dlx2, Gsh2, Mash1, Vax1 into the 
pallium (Corbin et al. 2000; Stoykova et al. 2000; Toresson et al. 2000; Kroll et al. 
2005). In addition, to these intrinsic mechanisms involving gene regulation, extrinsic 
mechanisms have also been considered especially at later stages of telencephalic 
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development. In fact, it has been shown that thalamo-cortical axons (TCAs) may 
influence the specification of its different areas. However, further studies are 
required to clarify these mechanisms (O'Leary et al. 2007)(Figure 1.4). 
36 
 
Figure 1.4 Patterning centers and genes expressed in the developing 
forebrain.  
 
A: Positions of the different patterning centers in the developing embryos. The table 
lists key molecules and their corresponding expression patterns.  
B: Graded expression of Emx2, Pax6, Coup-TFI, and Sp8 along the anterior-
posterior and lateral-medial axes. Emx2 is expressed in a high P-M to low A-L 
gradient. Pax6 expression pattern is opposite to that of Emx2, with a high A-L to low 
P-M gradient. Coup-TFI has a high P-L to low A-M gradient. Sp8 is expressed in a 
high A-M to low P-L gradient. While the expression of Emx2, Pax6, and Coup-TFI is 
sustained in the VZ, Sp8 expression is quickly downregulated around the onset of 
cortical neurogenesis.  
C: In the anterior signaling center, Fgf8 establishes the low anterior-graded 
expression of the TFs Emx2 and COUP-TFI by repression, and promotes the high 
anterior gradient of Sp8 expression. Fgf8 expression is also regulated positively by 
direct transcriptional activation by Sp8 and indirectly by Emx2, which represses the 
ability of Sp8 to directly induce Fgf8. Putative posterior signaling molecules Bmps 
and Wnts, expressed in the CH, positively regulates the high caudal gradient of Emx2 
expression.  
D: Summary of all reports of loss-of-function or gain-of-function mouse mutant for 
TFs that regulate area patterning. Reducing Emx2 levels in the cortex of the 
heterozygote mutant mice results in posterior shifts of areas, while overexpression of 
Emx2 under the control of the Nestin promoter shifts areas anteriorly. The small eye 
mutant shows anterior area shifts and YAC transgenic mice of Pax6 do not show 
area changes other than a slight, but significant, reduction in the size of S1 (asterisk). 
Loss of COUP-TFI in cortical progenitors transforms the fate of primary sensory 
areas into frontal/motor areas. The analysis of Sp8 conditional knockout mice shows 
anterior shifts of gene markers. 
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(A is modified from Rakic et al. 2009; B-D are modified from O'Leary et al. 2007) 
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1.3.2 Specification of pyramidal neurons 
 
As neurogenesis begins, cortical neuroepithelial cells start to differentiate. 
Specific TFs are involved in maintaining the right equilibrium between proliferation 
and differentiation. The basic Helix-Loop-Helix (bHLH) molecules are among the 
TFs tightly involved in these processes. For example, the telencephalic proneural 
genes Neurogenin1 (Ngn1) and Neurogenin2 (Ngn2) (Fode et al. 2000; Nieto et al. 
2001) regulate the key steps of commitment of stem cells to the neuronal fate, cell 
cycle exit and initiation of a neuronal differentiation program. Double mutants for 
Ngn2 and Mash1 show reduced cortical neurogenesis (Fode et al. 2000; Nieto et al. 
2001). In wild-type mice, expression of Ngn1 and -2 in dorsal telencephalic 
progenitors, direct the differentiation of neurons towards a glutamatergic phenotype 
(Schuurmans et al. 2004). Ngn1 and 2 mutant animals present defects in expression 
of laminar-specific markers in early-born neurons in layers VI and V, while late-born 
neurons in layers IV and II/III appear to be normal (Schuurmans et al. 2004).  
Once cells are committed, additional TFs, such as Tbr1, Ctip2 and Cux1/2, 
consolidate differentiation of the projection neuron phenotype and begin to specify 
projection neuron subtypes related to their laminar fate. In the developing cortex, 
Cux1 and Cux2, two homologues of Drosophila Cut gene, are specifically expressed 
in the VZ and in mitotically active cells of the SVZ, respectively, whereas later on 
their expression is confined to distinct subpopulations of the upper cortical layers 
(Schuurmans et al. 2004; Zimmer et al. 2004). Interestingly, the expression of Cux2 
and Cux1 in the upper cortical layers is severely diminished in the Pax6-mutant 
cortex, suggesting that these two genes might also act in the specification of the 
upper cortical layer neurons in a Pax6-dependent pathway (Schuurmans et al. 2004; 
Zimmer et al. 2004). Tbr1 and Ctip2 have been involved, instead, in the specification 
of neurons in lower layers (Molyneaux et al. 2007; Guillemot et al. 2006). 
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1.3.3 Specification of interneuron progenitors 
 
The embryonic subpallium or ventral telencephalon contains amongst other 
structures the MGE, LGE, CGE and AEP/POA domains. These subpallial domains 
express specific genes, such as Dlx1, Dlx2, Gsh1, Mash1, Gsh2, Nkx2.1, Nkx5.1, Isl1, 
Six3 and Vax1 that define their identities and are involved in the specification of 
interneurons and oligodendrocytes (Marin et al. 2003). Dlx homeobox genes are 
transcription factors that act as critical molecular determinants in forebrain 
development (Panganiban et al. 2002). They are specifically required to co-ordinate 
the timing of GABAergic interneuron migration and neuronal process formation 
(Anderson et al. 1997; Yun et al. 2002). In double Dlx1 and Dlx2 null mutants, 
migration is almost abolished and cells accumulate in the GEs (Cobos et al. 2005; 
2006; 2007). Ectopic expression of Dlx has been shown to induce GAD65/67 
expression in neuronal progenitors of the cerebral cortex normally committed to a 
glutamatergic phenotype (Stuhmer et al. 2002). Interestingly, Dlx1 single null 
mutants show no migrational defects. Recent studies suggest that DLX factors do not 
only have a role in migration, but also in morphogenesis of interneuron subtypes. 
Thus, abnormal dendritic morphology has been reported in subsets of somatostatin 
(SST) and Calr interneurons in Dlx1 and Dlx2 double-null mutants (Cobos et al. 
2005). Another homeobox transcription factor, Nkx2.1, appears to play a pivotal role 
during the commitment of interneuron progenitors. In fact, Nkx2.1 is fundamental for 
the correct MGE specification (Sussel et al. 1999), whereas LGE development is 
affected by the expression of Gsh2 (Hsieh-Li et al. 1995). Expression of Pax6 also 
distinguishes the LGE from the MGE and may contribute to the specification of the 
former. The AEP/POA territory, adjacent to the MGE, is also specified by Nkx2.1 
expression but, although the expression of common transcription factors indicates 
that MGE and AEP/POA may share some properties, progenitors arising from these 
structures appear molecularly distinct (Flames et al. 2007). These results suggest that 
the MGE and AEP/POA are anatomically defined sites characterised by distinct gene 
expression domains, Gsh2 and Lhx7 for the former and Nkx5.1 for the latter. As such, 
they give rise to distinct populations of cortical interneurons (Xu et al. 2004; Butt et 
al. 2005). 
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Earlier in vitro and in vivo experiments on the origins of interneuron subtypes 
suggested that they arise from different subpallial progenitor pools (Fishell, 2007). 
More recent in vitro experiments have shown that expression of Nkx2.1 in the MGE 
is required for the specification of MGE-derived interneurons. Upstream of Nkx2.1, 
the morphogen Shh appears to play a critical role in the establishment of Nkx2.1 
expression in the MGE (Sussel et al. 1999; Fuccillo et al. 2004) and in the 
maintenance of its expression during neurogenesis (Xu et al. 2005). Thus, mice 
carrying mutations in Shh expression within the neural tube fail to express the 
interneuron fate-determining gene Nkx2.1 in the MGE. This effect was also 
reproduced by inhibiting SHH signalling in slice cultures (Gulacsi et al. 2006). 
Recent lineage experiments using the Cre/loxP system have shown that another 
member of the Nkx gene family, Nkx5-1, appears to specify a population of early 
post-mitotic AEP/POA cells towards interneuron fate (Gelman et al. 2009) (Figure 
1.5). 
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Figure 1.5 Drawings of medial (A), caudal-intermediate (B) and caudal (C) 
coronal sections of E13.5 mouse brain showing the expression of different genes 
in the subpallial domain  
 
Broken lines delineate the VZ. Sub-domains that express two or more genes are 
marked with stripes.  
D: A summary of the expression of different genes in the LGE, MGE, CGE and 
POA.  
 
++: High level of expression, +: lower level of expression, -: lack of expression.  
CGE: caudal ganglionic eminence, Gp: globus pallidus, H: hippocampus, MGE: 
medial ganglionic eminence, NCx: neocortex, LGE: lateral ganglionic eminence, 
POA: preoptic area, St: striatum, Th: thalamus. 
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(F. Chiara from review Hernandez-Miranda et al. 2010) 
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1.4  MODES OF CELL MIGRATION IN THE EMBRYONIC CORTEX 
 
Cell migration is a crucial process involved in the proper assembly of the cerebral 
cortex. Two major types of neuronal migration have been implicated in 
corticogenesis: radial migration of pyramidal neuron precursors and tangential 
migration of interneurons as well as of CR cells.  
 
1.4.1 Radial migration of pyramidal cell precursors 
 
Pyramidal cell progenitors, born in the pallial VZ/SVZ, migrate radially towards 
the CP and eventually form the cortical layers. The formation of the cortical 
lamination in an “inside–out” manner requires precise guidance of these neurons 
from the VZ to CP (Ayala et al. 2007). Generation of these cells occurs through a 
combination of three different modes of cell division: symmetrical division that 
expands the pool of neuronal progenitors, asymmetrical division that gives rise to a 
self-renewed progenitor and a neuron, and symmetrical terminal division that 
produces two neurons, thus depleting the pool of proliferating cells (Mione et al. 
1997). Retroviral labeling techniques and time-lapse experiments have shown that 
radial glia cells mainly populate the VZ. These cells predominantly undergo 
asymmetrical division giving rise to a self-renewed radial glia cell and a daughter 
cell, which migrates away from the ventricle. A small percentage of asymmetric 
divisions produce a self-renewed radial glia cell and an intermediate progenitor cell 
that undergoes symmetrical division in the SVZ to produce upper cortical layer 
neurons (Noctor et al. 2004). The process of migration progresses through different 
phases. Firstly, the newborn neuron assumes a bipolar shape and migrates in the SVZ 
where it acquires a multipolar shape. Subsequently, the neuron contacts the ventricle 
through a leading process and migrates retrogradely. Finally, after contacting the 
ventricle, it acquires a bipolar morphology and migrates towards the CP (Noctor et 
al. 2004). Radial glia cells born in the VZ at early stages during development mostly 
guide radial migration of pyramidal cells. Structurally, each cell has its body in the 
VZ and a long process that reach the pial surface. Radial glia cells have two main 
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functions during embryonic development: they are a source of neuronal precursors 
and also provide a scaffold for their radial migration (Parnavelas et al. 2001). After 
birth, radial glia cells differentiate into astrocytes. Molecular abnormalities that 
affect radial glia development can also cause defects in neuronal progenitor 
migration (Hatten 1999; Marin et al. 2003). Two major modes of radial neuronal 
migration have been identified in the cortex: somal translocation and glia-guided 
locomotion (Nadarajah et al. 2001; Borrell et al. 2006; Rakic et al. 2007). During 
early corticogenesis, somal translocation is the predominant mode and some neurons 
appear to migrate solely by this mode. At later stages, locomotion becomes more 
common, but these neurons switch to somal translocation when their leading 
processes reach the pial surface. The cells that undergo somal translocation typically 
have a long, radially oriented basal process that terminates at the pial surface, and a 
short, transient trailing process. By contrast, cells that adopt glia-guided locomotion 
have a shorter radial process that is not attached to the pial surface and require a 
continuous formation and breakage of adhesive interactions with the radial glia. 
Integrins, a family of cell adhesion receptors mediating cell–extracellular matrix and 
cell–cell interactions, were long speculated to play a role in this process (Anton et al. 
1999; Schmid et al. 2004). Two main cellular events take place during neuronal 
locomotion: growth of the leading process and movement of the cell body and 
nucleus (nucleokinesis) (Tsai, et al. 2005).  
 
1.4.2 Tangential migration of interneurons  
 
Unlike projection neurons, the vast majority of GABA-ergic interneurons are first 
born in the subpallial VZ and migrate tangentially towards the cortex. This migration 
pattern by interneurons was originally established based on dye labelling of 
migrating cells as well as analysis of Dlx1/2 double mutant mice (De Carlos et al. 
1996; Anderson et al. 1997). The main source of cortical interneurons is the MGE. 
The LGE and the CGE also contribute in a small part (Marin et al. 2003; Metin et al. 
2006). Interneurons are guided from the ventral to the dorsal telencephalon by a 
combination of chemorepulsive (SLIT1 and semaphorins) and chemoattractive 
(neuregulin, SDF-1) factors. Tangential migration is independent of interactions with 
radial glia. Initially, interneurons enter in the developing cortex in defined streams at 
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the level of the PPL and IZ and, after the splitting of the PPL, through the MZ, SP 
and SVZ. It seems that, once interneurons reach areas where they will reside, they 
start to migrate radially, inward and outward, in the direction of the CP. Recent 
studies using time-lapse imaging and tracer-labelling techniques have also shown 
that interneurons, after reaching the developing cortex, migrate in the direction of the 
cortical VZ. This ventricle-directed morphological feature suggests the hypothesis 
that interneurons actively seek the cortical VZ to receive layer information that is 
essential for their correct positioning into the developing cortex (Nadarajah et al. 
2002). Finally, cortical interneurons position themselves in layers in an “inside-out” 
manner, together with pyramidal cells born at the same time. This suggests that 
projection neuron lamination and interneuron positioning are tightly coordinated. 
Indeed, in reeler cortex, interneurons have been found to adopt a similar inverted 
pattern of laminar positioning as projection neurons despite their independence of 
Reelin signalling (Pla et al. 2006). Recent studies found that the chemokine Cxcl12, 
also known as Stromal Cell Derived Factor-1 (SDF-1), plays a key role in this 
process (Lopez-Bendito et al. 2008). Cxcl12 is highly expressed along the streams of 
migrating interneurons in the MZ and SVZ, whereas its receptor Cxcr4 is expressed 
in interneurons. The specific migration patterns shown by different neuronal types in 
the developing cortex suggest that the genetic program regulating cell migration is 
part of neuronal cell fate specification.  
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1.5  CAJAL­RETZIUS CELLS 
 
Cajal–Retzius cells are a transient population that cover, like a sheet, the entire 
cortex early during development (Ramón y Cajal, 1911; Retzius, 1894; Soriano et al. 
2005). Cajal–Retzius cells, which are found in the PPL and subsequently in the MZ, 
display characteristic radial ascending processes that contact the pial surface, and a 
horizontal axon located in the deep MZ. These cells secrete Reelin, a molecule 
important for the correct formation of the cortical lamination (Soriano et al. 2005). In 
the dentate gyrus, Reelin expression by CR cells provides positional cues for 
organising granule cell lamination (Zhao et al. 2004). Transplantation of embryonic 
CR cells into the adult cerebellum also induces a transient rejuvenation of host 
Bergmann glia (Soriano et al. 1997). Moreover, ectopically positioned CR cells can 
reverse the direction of granule cell migration in cerebellar slices (Soriano et al. 
1997). Lastly, loss of function studies suggest that lack of the transcription factor 
Foxg1, which acts as a positive regulator of neuron proliferation and repressor of cell 
cycle exit in the pallial VZ, leads to abnormal differentiation of early-born cortical 
progenitors that adopt CR cell fate (Hanashima et al. 2004). This consequently 
causes an increased production of Reelin that alters the expression of a HLH 
transcription factor called Early B-cell factor 2 (Ebf2). The same effect 
(hyperproduction of CR cells and Reelin) has been observed in Glioma-associated 
gene 3 (Gli3) mutants (Hanashima et al. 2007). 
 
1.5.1 Origin, migration, functions and postnatal fate of CR cells 
 
More than a century after their discovery, CR neurons are still surrounded by 
controversy. Firstly, the origin of these cells has been elusive for a long time, but 
recent lineage tracing experiments have finally begun to clarify it. Cajal-Retzius 
neurons are amongst the earliest born cells in the neocortex, starting around E10–12 
in the mouse (Hevner et al. 2003). Electroporation experiments suggest that the vast 
majority of CR neurons are most likely generated in three locations: the CH 
(Takiguchi-Hayashi et al. 2004; Garcia-Moreno et al. 2007), the septum and the 
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ventral pallium (Bielle et al. 2005). In fact, fate mapping experiments using a Wnt3a-
Cre line to trace cells derived from the CH, confirmed that this structure gives rise to 
the vast majority of CR cells (Yoshida et al. 2006). Interestingly, ablation of the CH 
did not result in major perturbation of cortical layer formation (Yoshida et al. 2006). 
Further experiments, using a Dbx1-Cre line, have identified two additional sources 
for CR cells outside the cortex, including the ventral pallium and septum (caudally 
identified as AEP/POA) (Bielle et al. 2005). Recently, thalamic eminence has also 
been proposed as a possible source of CR cells (Tissir et al. 2009; Abellan et al. 
2010). After their birth, CR cells migrate tangentially to cover the entire cortical MZ. 
Cortical meninges have been found to act as substrate for CR cells as well as 
chemoattractant system during their migration. In fact, the chemokine Cxcl12 (or 
SDF-1) is expressed by the meninges and plays a role in attraction and dispersion of 
CR cells (Borrell et al. 2006). In addition, loss of Cxcr4, which is the receptor for 
Cxcl12, expressed by CR cells, results in failure of their migration. In fact, Paredes et 
al. (2006) found that, a disrupted meningeal basement membrane with loss of Cxcl12 
expression, results in CR cell displacement.  
A number of different TFs and nuclear proteins have been implicated in the 
control of CR cell differentiation, migration and survival. These TFs have also been 
used as markers of different CR cell populations: Tbr1, Pax6, Emx1 and Emx2 
(Mallamaci et al. 1998; Hevner et al. 2001; Muzio et al. 2003; Stoykova et al. 2003), 
p73 (Meyer et al. 2002), p21 (Siegenthaler et al. 2008), Zic 1-3 (Inoue et al. 2008) 
specify septal and hem derived cells, Er81 septal cells (Zimmer et al. 2010) and Ebf2 
the ventral pallium (Hanashima et al. 2007) (Figure 1.6 and Table 1.1). 
The postnatal fate of CR neurons is another subject of debate. Cells with the 
typical CR morphology are difficult to find in the adult cortex. One theory is that 
they undergo a morphological changes in order to become resident interneurons in 
adult neocortex (Parnavelas et al. 1983; Sarnat et al. 2002). Others have proposed 
that the decrease in CR neuron density is caused by dilution following the expansion 
of the cortex during development, without any morphological transformation (Marin-
Padilla, 1990). Recent experiments, using a Ebf2-GFP mice for in vivo two-photon 
imaging, have shown that the majority of CR neurons die by apoptosis during the 
second postnatal week and less than 3% of the population survive into adulthood 
(Chowdhury et al. 2010). So far, the best understood function of CR neurons is in 
cortical lamination. In fact, these cells secrete Reelin (Ogawa et al. 1995; Rice et al. 
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2001) to orchestrate neuronal migration in the typical “inside-out” pattern (Caviness, 
1982). However, in the last decade, studies showing phenotypic variability 
(Radnikow et al. 2002; Soda et al. 2003) and multiple origins of CR neurons (Bielle 
et al. 2005; Garcia-Moreno et al. 2007) support the hypothesis that these cells could 
evolve to carry out different functions throughout cortical development. It is known 
that CR neurons are capable of firing action potentials (Radnikow et al. 2002; Soda 
et al. 2003) and are spontaneously active (Schwartz et al. 1998; Aguilo et al. 1999; 
Soda et al. 2003). Moreover, gap junctions exist between CR cells and pyramidal 
neurons (Radnikow et al. 2002) and these cells can fire synchronously (Soda et al. 
2003). Lastly, Portera-Cailliau and colleagues have previously demonstrated that the 
axon tips of CR neurons have large growth cones that continue to grow during 
postnatal development (Portera-Cailliau et al. 2005). Together, these data suggest 
that CR neurons could influence network activity of pyramidal neurons. 
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Figure 1.6 Origins and migration of CR cells  
 
A-C: Schematic figures showing rostral and medial coronal sections of E11.5 and 
E13.5 mouse brain. PSPB, Sp, AEP/POA and CH between E10-E11.5 give rise to 
different subpopulation of CR cells that eventually will cover the surface of the entire 
pallium. Recently, TE has also been proposed as possible source of CR cells. These 
cells migrate tangentially into the pallium and their process of migration is 
completed by E13.5/E14.5. Different sites of origin for CR cell populations are 
characterised by the expression of different genes (See Table 1.1).  
 
AEP/POA: entopeduncolar area/preoptic area, CH: cortical hem, NCx: neocortex, 
PSPB: pallial subpallial boundary, PCx: pyriform cortex, Sp: septum, TE: thalamic 
eminences.  
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Table 1.1 Gene expressions in the different site of origins of CR cells 
 
Area  Gene expression 
Cortical hem Tbr1, Pax6, Emx1, Emx2, p73, p21, Zic 1-3, Ebf2-3, 
Calretinin, Reelin, Lhx6, Wnt-3a 
PSPB (Ventral Pallium) Dbx1, Reelin, Calretinin 
AEP/POA Tbr1, Pax6, Emx1, Emx2, p73, p21, Zic 1-3, Ebf2-3, 
Reelin, Er81 
Septum Dbx1, p73, Ebf2, Ebf3, Reelin, 
TE Δnp73, Reelin, Ebf3 
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1.5.2 Reelin 
 
Reelin is a secreted extracellular matrix protein containing 3461 amino acids, 
encoded by the Reln gene (D'Arcangelo et al. 1995; Ogawa et al. 1995; Tissir et al. 
2003). In Reeler mutants, a spontaneous mouse line carrying Reln mutation, the 
normal inside-out pattern of cortical formation is replaced by an inverted cortical 
lamination, where the PPL fails to split and neurons incorrectly position in the lower 
layers of the cortex (Caviness et al. 1973). Defects observed in mutant mice are more 
severe in the cerebral cortex, hippocampus and cerebellar cortex, but anomalies have 
also been found in other structures, such as the olfactory bulb and inferior olive. 
However, it is still poorly understood how Reln influences neuronal migration and 
proper lamination of the cortex. Reelin signal is received by migrating neurons by 
two redundant cell surface receptors, Very Low Density Lipoprotein Receptor 
(Vldlr) and Apolipoprotein E Receptor 2 (ApoER2), and double mutation of Vldlr 
and ApoER2 results in cortical lamination defects similar to Reeler mutants 
(D'Arcangelo et al. 1999; Hiesberger et al. 1999). Downstream of Vldlr and 
ApoER2, the adaptor protein Disabled-1 (Dab-1) is required for mediating Reelin 
signalling and Dab-1 mutant mice also display Reeler-like cortical lamination 
phenotypes (Howell et al. 1997). Thus, Reelin signalling is essential for cortical 
neurons for proper radial neuron migration and cortical layer formation.  
Recent analysis have shown that Vldlr and ApoER2 may play distinct roles in 
regulating cortical neuron migration: Vldlr may mediate a stop signal for migrating 
neurons, whereas ApoER2 may promote the migration of late born cortical neurons 
(Hack et al. 2007). Moreover, Reln has also been implicated in regulating neuronal 
dendrite and spine development (Niu et al. 2004; 2008). Interestingly, 
phosphatidylinositol 3-kinase (PI3K) signalling is required to mediate Reelin 
signaling downstream of Dab-1 in both neuronal migration and dendrite 
development, but neuronal migration is independent of mTOR (mammalian target of 
rapamycin) signalling which, in contrast, is required for Reln regulation of dendrite 
growth (Jossin et al. 2007).  
An alternative mechanism of Reelin signaling has been recently shown by Rakic 
and colleagues who implicated Notch signaling in Reelin regulation of radial neuron 
migration (Hashimoto-Torii et al. 2008). These authors found that Notch 
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Intracellular Domain (ICD), the proteolytic fragment of Notch that translocates to the 
nucleus when Notch receptor is activated, is significantly reduced in the Reeler 
cortex. Indeed, simultaneous deletion of Notch 1 and 2 from migrating neurons 
results in a phenotype similar to that in Reeler cortex. Most importantly, 
overexpression of Notch ICD in cortical neurons of Reeler mouse mitigates their 
migration defects.  
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1.6  THE TRANSCRIPTION FACTOR FAMILY Collier/Olf/Ebf 
 
One of the most important mechanisms to regulate cell-type function in somatic 
cells is the differential activation of tissue-specific genes. This is controlled by TF 
proteins that promote gene transcription by directly interacting with DNA. So far, 
many TF families have been characterized during cellular differentiation; one of 
these is the group of HLH proteins. The Collier/Olfactory/Early-Bcell (COE) TFs are 
a conserved family of HLH proteins present in vertebrate and invertebrate species. 
The first member of the COE family, Ebf1/OE-1 (or the rat orthologue Olf-1), was 
isolated as a TF that specifically binds promoters of various olfactory genes and the 
Mb-1 gene in developing B-lymphocytes (Hagman et al. 1995; Wang et al. 1997). 
Subsequently, additional members of the same family were isolated in mouse: 
Ebf2/OE-3, Ebf3/OE-2 and 0/E-4 (Garel et al. 1997; Malgaretti et al. 1997; Wang et 
al. 1997). Furthermore, EBF orthologues have been found in other organisms. In C. 
elegans, Unc-3 determines the ventral nerves fasciculation (Prasad et al. 1998; 
Liberg et al. 2002). In Drosophila, mutations in the Collier gene, a member of the 
COE family, lead to wing, head and muscle defects (Crozatier et al. 1996). Finally, 
in Xenopus Xebf2 and Xebf3 are involved in neuronal cell differentiation (Pozzoli et 
al. 2001). The mouse EBF proteins show 75% identity. EBF1 and EBF3 are the most 
similar, whereas EBF2 differs at the carboxy-terminal domain used to interact with 
other proteins. In humans, four Ebf orthologous genes were discovered: Ebf1-related 
(chromosome 5), Ebf2-related (chromosome 8), Ebf3-related (chromosome 10) and 
OE-4- related (chromosome 20). Phylogenetic analysis has revealed that the exons-
introns structure of Ebfs is conserved in different species (Crozatier et al. 1999; 
Dubois et al. 2001). 
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1.6.1 The structure of EBF proteins 
 
The COE family contains several conserved regions. This indicates that the 
specific structure is of crucial importance for the correct function of EBF proteins. 
Firstly, these factors, through a histidine and cysteine-rich domain of 250 amino 
acids located in the amino-terminal region of the protein, bind the specific DNA 
sequence. The DNA binding occurs in the presence of Zn2+ ions that binds a zinc 
finger-like motif made up by three cysteines and one histidine. Moreover, this 
structure, which is required for the DNA binding process, is highly conserved in all 
the COE proteins (Crozatier et al. 1999). 
Downstream of the DNA binding domain (DBD), there is a second conserved 
region with apparent similarity to an IPT/TIG (immunoglobulin-like, plexins, 
transcription factors/transcription factor immunoglobulin) domain also present in the 
DNA binding region of transcription factors such as NFAT and NF-kB (Aravind et al. 
1999). The role of this region is unclear although it has been suggested to be 
involved in the interaction with the Rat O/E-1 associated zinc finger (ROAZ) (Tsai et 
al. 1997). Another possibility comes from the findings that IPT plexin-rich domains 
are involved in axonal guidance and semaphorin signaling, suggesting a role of the 
COE proteins in neuronal migration (Prasad et al. 1998; Yu et al. 1999; Tamagnone 
et al. 2004). 
EBF1, EBF2, EBF3 and OE-4 bind DNA as homo- or heterodimers, and 
dimerisation is dependent on a region downstream of the DBD containing a HLH 
domain. The typical HLH contains two dissimilar amphipathic helices, helix 1 and 
helix 2, connected by a loop. EBFs do not contain any sequence corresponding to 
helix 1 but rather a duplication of helix 2 resulting in a domain that mediates 
dimerisation. The helix 2 duplication is only present in vertebrate EBFs and it can be 
deleted without affecting the capacity of the proteins to bind DNA (Wang et al. 
2002).  
EBF factors contain two transactivation domains, TSI located within the DBD and 
TSII in the C-terminal part of the protein with the ability to interact with other 
proteins. This region is poorly conserved amongst all the family members, 
56 
 
suggesting the potential of EBF proteins to interact with different factors and, as a 
result, play different roles during development (Hagman et al. 1995) (Figure 1.7). 
Figure 1.7 COE proteins structure  
 
A: Structure of mammalian EBFs. 
Green- Transactivation domain I. This includes the DNA binding domain and the 
zinc finger domain. Orange- IPT/TIG domain. Red- Helix1. Blue- dupliacated 
Helix2.Yellow- Transactivation domain II.  
B: Comparison between EBFs from different species. Mouse (mCOE), human 
(hCOE) and Xenopus EBF (xCOE) show high sequence similarity. Members of other 
species, such as Drosophila (dCOE), Zebrafish (zCOE) and C.elegans (cCOE) 
present variation at the transactivation domain II. 
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(Modified from Liberg et al. 2002) 
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1.6.2 The function of EBF proteins 
 
COE proteins play important roles during embryonic development, in particular 
during neurogenesis in different model systems. The Collier gene in Drosophila is 
fundamental for head and trunk segmentation and in the formation of a specific 
embryonic somatic muscle (Crozatier et al. 1996; 1999).  
COE proteins are also closely linked to Notch signalling during later inhibition 
events, which occurs during neuronal development. In Xenopus, Notch signalling 
suppresses neuronal differention downregulating the proneural gene bHLH X-
neurogenin-1. Xebf2 appears to act downstream of this protein, but upstream of the 
neurogenic xNeuroD, which seems to be activated by Xebf2. Xebf2 is, therefore, 
involved in maintaining high neural potential of precursor cells, but at the same time 
in promoting the commitment into neuronal fate by the activation of XneuroD. 
Instead, Xebf3 acts downstream of XneuroD stimulating the development of specific 
cell subtypes such as cranial sensory ganglia cells (Pozzoli et al. 2001). Furthermore, 
in C. elegans, the loss of expression of Unc-3, which is a member of the COE family, 
causes defects in specific motor neurons of the ventral nerve cord and in nerve 
fasciculation (Liberg et al. 2002). 
In chick embryos, Ebf gene function is necessary to initiate neuronal 
differentiation and migration towards the mantle layer in neuroepithelial progenitors, 
but is not required for cell cycle exit (Garcia-Dominguez et al. 2003). Ebf genes, 
therefore, appear to control neuronal differentiation and migration, and may also play 
a role in cell commitment and specification. In mouse, Ebf1, Ebf2 and Ebf3 were 
originally studied for their expression in the olfactory epithelium, but they are also 
transiently expressed in postmitotic neurons during embryonic development in 
overlapping as well as in different territories (Garel et al. 1997; Malgaretti et al. 
1997; Wang et al. 1997). Ebf1 and Ebf3, which map on mouse chromosomes 11 and 
7, respectively (Garel et al. 1997), are co-expressed at most sites in the mantle layer 
of the developing neural tube, whereas Ebf2, which maps on mouse chromosome 14, 
is expressed by postmitotic neural cells located in the subventricular layer of the 
spinal cord primordium (Garel et al. 1997; Malgaretti et al. 1997). In the developing 
nervous system, the functions of Ebf1 and Ebf3 appear to be redundant. The Ebf1 null 
mouse was originally reported to develop normally due to the redundant function of 
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Ebf3. However, there are defects in the striatum and in the facial motor nucleus, 
where Ebf1 is the only gene of the COE family to be expressed (Garel et al. 1997; 
1999). Moreover, in Ebf1 null animals a subset of thalamic axons does not reach the 
neocortex, and the projections that do form between thalamic nuclei and cortical 
domains have a shifted topography in the absence of regionalisation defects in 
thalamus or cortex (Garel et al. 1999; 2000).  
There is evidence to suggest that COE proteins interact with ROAZ that is 
involved in bone morphogenetic signalling (BMP). ROAZ, acting together with 
Smad, activates Xvent-2. The impaired ability of ROAZ to stimulate Xvent -2 in 
response to BMP-2, due to ectopic expression of COE, suggests that COE might be 
involved in modulation of BMP signaling during development (Hata et al. 2000). So 
far, target genes of EBFs have not yet been identified, but it has shown recently that 
IGF-1 (Insuline growth factor-1) may be a target candidate gene of Ebf2 involved in 
Purkinje cell survival (Croci et al. 2011).  
COE proteins are also expressed in the developing cerebellum. Ebf1 and Ebf3 are 
broadly expressed during embryonic development and postnatally in the Purkinje 
cells, whereas Ebf2 is expressed in a specific subpopulation of postmitotic Purkinje 
cells (Corradi et al. 2003; Croci et al. 2006). Furthermore, studies have shown that 
Ebfs are transiently expressed in the cerebral cortex; specifically Ebf2 and Ebf3 have 
been found to be expressed in CR cells during corticogenesis (Yamazaki et al. 2004; 
Hanashima et al. 2007; Chowdhury et al. 2010). Outside the nervous system, EBFs 
are involved in the development of B-lymphocytes and in the genetic control of the 
adipogenic cascade (Sigvardsson et al. 2002; Jimenez et al. 2007) (Table 1.2). 
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Table 1.2 Expression roles and putative targets of the COE factors  
(Dubois et al. 2001) 
 
Species/gene name Expression Role 
Rodent         CNS and PNS: differentiating post-mitotic 
neurons 
Olfactory neuron precursors and mature 
neurons 
Subventricular zone of laterl ganglionic 
eminence 
Differentiating facial brachiomotor (fbm) 
neurons 
Pro-B and pre-B lymphocytes 
 
PNS, CNS subventricular zone of neural tube 
Progenitors of fbm neurons 
Bones development and adipogenic cascade 
 
 
CNS and PNS: differentiating post-mitotic 
neurons 
Progenitors of fbm neurons 
Differentiation of striatal neurons 
Control of fbm migration 
Cerebellum development 
Specification of B-cells 
(Ebf1-/- mouse available) 
 
Purkinje cells development in the 
cerebellum. Expressed in Cajal-Retzius 
cells in the cerebral cortex. 
(Ebf2-/- mouse available) 
 
Expressed in Cajal-Retzius cells and 
Purkinje cells. (Ebf3-/- mouse is not 
available) 
Xenopus Precursors of primary neurons 
 
 
Differentiating primary neurons 
Commitment of primary neurons. 
(Notch signaling) 
 
Differentiation of primary neurons 
(Notch signaling) 
Drosophila          Collier Embryonic head 
Progenitor and precursor cells of somatic 
muscle DA3 
Central region of the wing disk 
Formation of head 
Muscle specification  
 
Patterning of the wing 
C.elegans            Unc-3 Ventral motor neurons Axonal pathfinding 
 
Ebf1/ 
Olf-1 
 
 
 
 
 
 
Ebf2 
 
 
 
 
 
 
 
Ebf3 
xEbf2 
 
 
xEbf3 
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1.6.3 Ebf2-/- mice 
 
Ebf2 -/- mice were generated by target mutation within the insertion of a 
promoterless LacZ cDNA that replaced the translation initiation site and the first five 
exons of the gene. Although Ebf2-/- mice complete the embryonic development 
successfully, mutants show defects in different territories (Corradi et al. 2003). 
Firstly, in the CNS, the migration of gonadotropin-releasing hormone (GnRH) 
neurons from the vomeronasal organ to the hypothalamus is defective, although Ebf1 
is co-expressed with Ebf2. However, Ebf2 is not required for the birth of these 
neurons. As a result, the formation of the neuroendocrine axis is impaired and 
homozygotes adult mice show hypogonadotropic hypogonadism characterised by 
testis hypoplasia in the absence of Leydig cell hyperplasia and sterility (Corradi et al. 
2003). Moreover, Ebf2-/- mice are characterised by disruption of the cerebellar 
corticogenesis. In fact, the cerebellum is dramatically reduced in size with foliation 
defects, especially in the anterior vermis. Ebf2-/- mice show a typical ataxic gait 
closely associated with the abnormalities of the cerebellar development. During 
embryogenesis, Ebf2 is strongly expressed in a postmitotic subpopulation of Purkinje 
cells, in domains that are also positive for Ebf1 and Ebf3. The fact that the cerebellar 
cortex is malformed in the Ebf2-/- suggests that EBF2, despite the tight structural 
similarity to EBF1 and EBF3, may actually exert distinct functions in Purkinje cell 
development. The Ebf2-/- mutation does not affect cell proliferation or cell cycle exit, 
and the development of Bergmann glia cells appears normal. Conversely, the mutant 
cerebellum displays a clear defect in the migration of a subset of Purkinje cells. At 
birth, numerous delayed-migrating Purkinje cells accumulate in the proximity of the 
ventricular zone and subsequently die by apoptosis. Furthermore, Ebf2 expression in 
the wild-type cerebellum is restricted to ZebrinII (ZII)-negative Purkinje cells, and in 
the Ebf2-/- cerebellum ZII-negative Purkinje cell stripes are selectively disrupted 
leading to strong changes in the cerebellar topography (Croci et al. 2006). In addition 
to defects in the CNS, Ebf2-/- mice feature glial and axonal defects in the sciatic 
nerve. These include incomplete axon sorting, which results in defective axonal 
fasciculation. In parallel, mutant nerves feature signs of segmental dysmyelination 
and hypomyelination (Corradi et al. 2003). Ebf2+/- animals are reported to develop 
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normally, suggesting that Ebf2 function could be gene dosage dependent (Croci et al. 
2006).  
Finally, outside the nervous system, EBF2 is expressed in osteoblast progenitors 
as a regulator of osteoclastogenesis and bone homeostasis through the activation of 
osteoprotegerin (OPG). Ebf2-/- mice show reduced bone mass and an increase in the 
number of osteoclasts due to a downregulation of the expression of OPG (Kieslinger 
et al. 2005) (Figure 1.8). 
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Figure 1.8 β-Gal expression in Ebf2-/- mice  
 
A- C: Ebf2 expression in three mouse embryos at different developmental stages. 
Ebf2 is strongly expressed in the telencephalon at E11.5, but its expression is 
subsequently downregulated in this region at E13.5 (black arrows) (Croci L., G. G. 
Consalez, unpublished). 
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1.7  AIMS 
 
The regulated expression of specific genes is tightly associated with the correct 
development of different organs (e.g. brain) into the complex structure that 
characterise adult animals. Mutations that disrupt these mechanisms may lead to 
dramatic defects. In this work, I will analyse the role of a novel group of genes, 
called Ebfs, in telencephalic specification. So far, it is known that EBF factors play a 
pivotal role in various aspects of neuronal development. In particular, it has been 
found that Ebf2 is involved in neuronal fate determination and migration. Absence of 
this factor leads to striking defects in mice, especially in the correct development of 
the cerebellar cortex. Studies on Ebf2 have been focused on its characterisation in the 
midbrain and hindbrain, but the role Ebf2 expression during forebrain development 
still needs to be clarified. In particular, recent studies have suggested a correlation 
between CR cells and Ebf2 expression, but it is still unkown whether lack of 
expression of this gene could lead to severe defects in this specific cell population. 
Moreover, due to the high sequence similarity between the COE members, I will 
assess whether EBF2 function in the cerebral cortex could be influenced by other 
EBF proteins. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
 
 
 
 
 
2.1  MATERIALS 
 
2.1.1  Buffers 
All solutions were prepared with reagents from Sigma-Aldrich Company Ltd 
(Dorset, England) unless otherwise stated. 
 
Artificial Cerebrospinal Fluid (ACSF) 
25 mM KCl, 2 mM KH2PO4 25 mM HEPES, 37 mM D-Glucose, 10 mM MgSO4, 
175 mM Sucrose, 0.5 mM CaCl2 in double-distilled (dd)H2O. Adjust pH to 7.4 with 
NaOH. Add penicillin/streptomycin (5000 units of Penicillin/5000 µg Streptomycin, 
Gibco-Invitrogen Ltd, Paisley, UK) and filter with 0.2 µm membrane (Millipore, 
Watford, UK) 
 
In Situ Hybridisation Buffer 
50% Formamide (Roche), 5X SSC, 1% SDS, 500 µg/ml tRNA (Roche-Applied 
Science, Newhaven, UK), 200 µg acetylatedBSA, 50 µg/ml Heparin 
 
NTMT 
100 mM NaCl, 100 mM Tris-HCl pH 9.5, 50 mM MgCl2, 1% Tween20, 2 mM 
Levamisole in ddH2O 
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1X Phosphate Buffered Saline (PBS)  
2 mM KH2PO4, 8 mM Na2HPO4, 2.5 mM KCl, 140 mM NaCl, add ddH2O and 
adjust  
pH to 7.2-7.3. For PBST 0.2% of TritonX-100 was added 
4% Paraformaldehyde (PFA)  
4 % PFA, 1X PBS to volume, adjust to pH 7.4 by adding 10 M NaOH 
 
Proteinase K (PK) Buffer for genotyping  
50 mM Tris-HCl pH8, 100 mM EDTA pH8, 100 mM NaCl, 0.5% SDS(20%) in 
ddH2O 
 
Permeabilisation (P) Solution  
10 g Sucrose, 1 ml 5 M NaCl, 300 µl 1 M MgCl2, 2 ml 1 M Hepes pH 7.4, 2.5 ml 
20% TritonX100 
 
10X Running Buffer 
250 mM Tris Base, 1.9 M Glycine, 10% Methanol, 1% SDS 
 
Ripa Buffer 
150 mM NaCl, 1% NP-40, 0.5% DOC (deoxycholic acid), 0.1% SDS, 50 mM 
Tris pH 8.0, ddH2O to volume 
 
20X Saline Sodium Citrate Buffer (SSC)  
175.3 g di NaCl and 88.2 g di NaCitrate add ddH2O to volume of 1 L 
 
TE STOP Buffer 
10 mM Tris-HCl pH7.5, 10 mM EDTA pH 8.0 and ddH2O to volume 
 
10X Transfer Buffer 
250 mM Tris Base, 1.9 M Glycine, 10% Methanol 
 
1X Tris Acetate Buffer (TAE) 
0.4 M Tris pH8, 0.2 M Sodium Acetate, 20 mM EDTA pH8 in ddH2O 
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10X Tris Buffered Saline (TBST)  
100 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Tween-20 in ddH2O. Working 
solution was diluted to 1X in ddH2O 
2.1.2 Cell Culture Buffers 
 
Cell Line Culture (CLC) Medium 
Dulbecco’s Modified Eagle Medium (DMEM), 10% Fetal Bovine Serum (FBS, 
Gibco), 2 mM L-Glutammine (Gibco), 2500 units Penicillin/2500 µg Streptomycin 
(Gibco) 
 
Slice Medium 
DMEM-F12, 5% FBS (Gibco), 1X N2 Supplement (Gibco), 100 µM L-
Glutammine (Gibco), 2.4 g/L D-Glucose, 2500 units Penicillin/2500 µg 
Streptomycin (Gibco) 
 
2.1.3 Animals 
 
Animals were maintained by UCL Biological Services. Experiments were 
performed in accordance to the personal licence and to Animal Act 1986 (UK). 
 
Mice 
The mouse lines Ebf2 +/-, Gt(ROSA)26Sortm1(EYFP)Cos (R26RYFP; Jackson 
Laboratories, first described in Srinivas et al., 2001) and Ebf2GFPiCre were kindly 
provided by Dr. G. G. Consalez (San Raffaele Scientific Institute, Milan, Italy). 
Experiments on Ebf2-/- mice were carried out on F1 hybrids obtained by crossing 
Ebf2+/- pure-bred FVB/N (N9) females with Ebf2+/- pure-bred C57BL/6J males. This 
hybrid strain was chosen to obviate the low fertility and poor maternal behavior of 
C57BL/6J heterozygous mothers, as described before (Croci et al. 2006). All studies 
were conducted using wild-type control littermates. CD1 pure-bred mice were used 
for in utero electroporation experiments. 
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2.2  TABLES OF MATERIALS 
 
Table 2.1 Primers for genotyping 
 
MOUSE 
LINE 
FORWARD (5’3’) REVERSE (5’3’) FRAGMENT SIZE 
(bp) 
Ebf2 -/-  GAGGCGGCAGATCTGAAG Wt-CCAATGCTGCCAGCAAATG 
Mutant-
CATTCAGGCTGCGCAACTGTT 
Wt-250 
Mutant-600 
Ebf2GFPiCre ATGGTGCCAAGGATGACTCT CCTCGAGCAGCCTCACCA 250 
R26RYFP Wt-
GCGAAGAGTTTGTCCTCAACC 
Mutant-
AAAGTCGCTCTGAGTTGTTAT 
GGAGCGGGAGAAATGGATATG Wt-600 
Mutant-250 
 
Table 2.2 Primers for RT-PCR 
 
GENE   PRIMER SEQUENCE (5’3’) FRAGMENT 
SIZE (bp) 
SPECIES 
mEbf1-F AGGTTGGATTCTGCTACGAAAGTT  mouse 
mEbf1-R TCAGGCCTTTTTAAGAGGAATCA 80  
    
mEbf2-F TGGAGAATGACAAAGAGCAAG  mouse 
mEbf2-R TTTGAAAACAGCGGGAAACCC 330  
    
mEbf3-F TCGTGAATATGCACCGTTTTG   
mEbf3-R CCTCGAGACATTTTTTCTGTACTCAT 76 mouse 
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Table 2.3 Plasmids for cell transfection  
 
NAME  5’ TAG  PLASMID SUPPLIER 
Ebf1-flag  FLAG  pcDNA 3.1 G. G. Consalez 
Ebf2-flag  FLAG  pcDNA 3.1 G. G. Consalez 
Ebf3-flag  FLAG  pcDNA 3.1 G. G. Consalez 
shEbf1  GFP  pcDNA 6.2 G. G. Consalez 
shEbf2  GFP  pcDNA 6.2 G. G. Consalez 
shEbf3  GFP  pcDNA 6.2 G. G. Consalez 
shEbf1-2-3  GFP  pcDNA 6.2 G. G. Consalez 
shMock  GFP  pcDNA 6.2 G. G. Consalez 
 
Table 2.4 In situ probes 
 
NAME ENZYME for 
linearization 
POLYMERASE SPECIES SUPPLIER 
Dbx1 EcoRI T7 mouse T. Shimogori  
Ebf1 XhoI T3 mouse G.G. Consalez  
Ebf2 XhoI T3 mouse G.G. Consalez  
Ebf3 SalI T3 mouse G.G. Consalez  
FoxG1 BamHI T7 mouse A. Mallamaci  
GFP BamHI T3 mouse T. Shimogori  
Reelin HindIII T3 mouse T. Shimogori  
Wnt3a EcoRI T7 mouse T. Shimogori  
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Table 2.5 Primary antibodies 
 
ANTIGEN HOST  CLONE DILUTION SUPPLIER 
Ctip2 rat Polyclonal 1/1000H Abcam 
GFP rabbit Polyclonal 1/3000H Abcam 
GFP chicken Polyclonal 1/500H Aves 
pan-Ebf rabbit polyclonal 1/2000WB Gift from G. G. Consalez 
Reelin mouse Monoclonal 1/3000H Gift from F. Goffinet 
Nurr1 rat Polyclonal 1/100H Gift from Z. Molnar 
p73 goat Polyclonal 1/100H Santa Cruz 
Cux1 rabbit Polyclonal 1/100H Santa Cruz 
α-tubulin mouse Monoclonal 1/5000WB Sigma 
Paravalbumin mouse Monoclonal 1/500H Sigma 
α-FLAG mouse Monoclonal 1/100H Sigma 
Calbindin Rabbit Polyclonal  1/5000H Swant 
Calretinin Rabbit  Polyclonal  1/2000H Swant 
 
H: Immunohistochemistry, WB: western blot. 
Abcam, Cambridge, UK; Aves Labs, Oregon, USA; RnD Systems, Abingdon, UK; Santa 
Cruz, Heidelberg, Germany; Swant, Bellinzona, Switzerland 
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Table 2.6 Secondary antibodies 
 
ANTIBODY HOST CONJUGATED 
WITH 
DILUTION SUPPLIER 
Anti-mouse IgG goat Biotin 1/200 Vector 
Anti-rabbit IgG goat Biotin 1/200 Vector 
Anti-rat IgG goat Biotin 1/200 Vector 
Anti-goat IgG donkey Biotin 1/200 Vector 
Anti-chicken IgG goat FITC 1/1000 Invitrogen 
Anti-mouse IgG goat FITC 1/1000 Invitrogen 
Anti-rabbit IgG goat FITC 1/1000 Invitrogen 
Anti-rat IgG goat FITC 1/1000 Invitrogen 
Anti-rat IgG donkey TRITC 1/1000 Invitrogen 
Anti-mouse IgG goat TRITC 1/1000 Invitrogen 
Anti-rabbit IgG goat TRITC 1/1000 Invitrogen 
Anti-mouse IgG goat HRP 1/5000 Amersham 
Anti-rabbit IgG goat HRP 1/5000 Amersham 
 
FITC: fluorescin-5-isothiocyanate (Alexa Fluor 488), TRITC: tetramethilrhodamine-5-(and 
6)- isothiocyanate (Alexa Fluor 568), HRP: horse radish peroxidase. 
Vector, Peterborough, UK; Amersham, GE Healthcare, Netherlands 
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2.3  METHODS 
 
2.3.1 Extraction of nucleic acids from tissues/cells 
 
DNA extraction from tissues 
DNA was extracted from mouse tissues (ear notches for adults and yolk sacs for 
embryos) and analyzed by PCR reaction. 
Tissues were incubated overnight (ON) in PK Buffer plus Proteinase K (1mg/ml, 
Sigma) at 55°C. Genomic DNA was extracted with phenol-chloroform, precipitated 
with 100% iso-propanol and eluted in ddH2O. 
DNA was analyzed by Polymerase chain reaction (PCR) using different primers 
to discriminate wild-type, heterozygous and knock-out/transgenic animals (See Table 
2.2.1). 
 
RNA extraction from cells  
RNA was extracted from cells using a commercially available kit from Qiagen 
(West Sussex, UK). RNA was eluted in ddH2O. Genomic DNA contamination was 
eliminated by treating with DNAaseI (Invitrogen) according to manufacter’s 
instructions. RNA was retro-transcribed into DNA prior to analysis according to the 
protocol shown below. Specific primers were used for the analysis of extracted RNA 
(See Table 2.2.2). 
 
2.3.2 Analysis of DNA/RNA samples 
 
Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
First strand DNA was synthetised from RNA using the kit SuperscriptII RT 
(Invitrogen). Briefly, 500 ng of RNA were mixed with Oligo dT, dNTPs and ddH2O 
up to 12 µl following the manufacturer’s instructions. The mix was incubated at 
65°C for 5 minutes (min) and chilled on ice.  First Strand Buffer, DTT and RNAasin 
were added to the mix and incubated at 42°C for 2 min. Subsequently, 200 units of 
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Superscript II Polymerase were added and the samples incubated at 42°C for 1 hour 
(h). The reaction was stopped by heating the sample at 75°C for 15 min. 
Each reaction was performed in a total volume of 20 µl. Products were amplified 
by using a non-proof reading Taq Polymerase (Promega, Dublin, IR). The mixture 
was composed of 50 ng of DNA, 1X Taq Buffer, 1.5 mM MgCl2, 0.2 mM dNTPs, 
0.5 µM Forward and Reverse primers, 1.25 units of Taq and ddH2O to final volume.  
The general PCR conditions used were the following: 
INITIAL DENATURATION: 95°C, 2 min; 
DENATURATION: 95°C, 30 secends (sec); 
ANNEALING: temperature was set according to the composition of the primers  
(Tm=2x (nA+nT) +4x (nG+nC)) and duration was usually between 30 sec and 1 min. 
EXTENSION: temperature was set at 72°C and duration was set according to the 
size of the fragment to be amplified and the processing capacity of Taq (1 kb for 1 
min). 
FINAL EXTENSION: 72°C, 5 min. 
PCR products were analyzed on 1 or 2% agarose gel electrophoresis as described 
below.  
 
Agarose gel electrophoresis 
1%-2% agarose gel was used to resolve DNA samples according to the size of 
amplified product. Agarose powder was melted in 1X TAE by heating the mix with a 
microwave and 0.2 µg/ml Ethidium Bromide was added. The solution was poured in 
a gel tray with a comb and left to set at RT for 30 min. Samples were mixed with 
Loading Buffer (Promega) and the gel was run in the appropriate apparatus (Bio-
Rad, Hertfordshire, UK). For fragment size identification a ladder (Promega) was run 
together with the PCR samples. 
 
2.3.3 Cell cultures 
 
COS7 cells 
COS7 cells were obtained from African green monkey kidney and transformed 
with SV40. These cells were cultured in CLC medium at 37°C in 5% CO2 in a 
humified incubator. They were passaged by trypsinasation in 0.25% trypsin/1 mM 
76 
 
EDTA (Gibco) until cells were detached from the plate. Activity of trypsin was 
stopped by adding NCC medium. COS7 cells were transfected with Ebfs-flag 
plasmids and/or shEbfs (see Table 2.2.3) with Lipofectamine2000 according the 
manufacturer’s instructions (Invitrogen). Three days after transfection, cells were 
either fixed with 4% PFA for immunohistochemistry or collected for RNA and/or 
proteins extraction. The transfection efficiency was calculated 48 h post-transfection 
by counting the number of flag/GFP-positive cells in 10 random fields imaged with a 
20 X objective. 
 
GN11 cells 
The GN11 cell line was obtained by genetically targeted tumorigenesis of 
gonadotropin-releasing hormone (GnRH) neurons in mice (Radovick et al., 1991). 
This cell line was a kind gift of A. Cariboni and R. Maggi (University of Milan, 
Italy). GN11 cells show high migratory behavior in vitro and are, therefore, a good 
model for studying molecular mechanisms of neuronal migration (Maggi et al. 
2000). Cells were cultured, propagated and treated as described for COS7 cells. 
GN11 cells were transfected with Ebfs-flag and shEbfs (Table 2.2.3) using 
Lipofectamine2000 (Invitrogen) and used to perform in vitro migratory assays, 
RNA/proteins extraction or fixed with 4% PFA for immunohistochemistry. The 
transfection efficiency was calculated 48 h post-transfection by counting the number 
of flag/GFP-positive cells in 10 random fields imaged with a 20 X objective. 
 
2.3.4 In vitro migration assays  
 
Chemomigration assay of GN11 neurons (Boyden chamber) 
Chemotaxis is a migratory response of cells to chemotropic gradients that can be 
studied with Boyden’s chamber (Boyden, 1962; Neuroprobe). The Boyden chamber 
contains two compartments, the upper cell chamber and the lower chemotropic 
chamber separated by PVP-free polycarbonate filter through which cells migrate. 
Filters have different pore sizes depending on cell type. For GN11 cells, pourous 
filter are treated with 0.5 M acetic acid, rinsed in 1X PBS and coated with gelatin.  
Transfected GN11 were trypsinised and resuspended in normal medium without 
FBS, as this was used as chemoattractant at a concentration of 1%. The same number 
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of cells was loaded in each well, and different conditions were tested (GN11 towards 
DMEM or towards DMEM+FBS). A gelatine coated membrane of pore size 8 µm 
was placed between the two compartments. GN11 cells were incubated for 3 h at 
37°C in a 5% CO2 humified incubator to allow migration. Subsequently, the 
migrated cells were fixed in methanol for 2 min, whereas the non migrated cells that 
had not migrated were attached to the upper surface of the membrane, and were 
scraped. Migrated cells were then stained with Tiazin and Eosin for 2 min each, 
rinsed in ddH2O and mounted onto a glass slide. The total cell number in 1 mm2 of 
three different fields for each well was counted. Results were expressed as a mean 
number of migrated cells per well+/- the standard error of the mean (SEM) and 
significance was calculated by the Student’s t-test (Microsoft Excell 2007). 
 
2.3.5 Extraction and analysis of proteins from cells or tissues 
 
Protein isolation from cells 
Cells were lysed in RIPA BUFFER containing protease (PMSF 1 mM, aprotinin 2 
µg/ml, leupeptin 5-10 µg/ml, pepstatin 1 µg/ml) and phosphatase inhibitors, and left 
on ice for 20 min. Adherent cells were scraped off the dish using a cold plastic cell 
scraper and then gently transferred into a pre-cooled tube.  
Cell suspension was centrifuge microcentrifuged using a at 4°C at 12,000 rpm for 
20 min and the supernatant collected. Protein concentration was determined using 
Bio-Rad Protein assay based on the method of Bradford. It utilizes the dye comassie 
blue g-250 wich is red of a pH below 1, but turns blue when binding to a protein 
causing a shift in the pKa of the bound dye. 1 µl of protein lysate was added to 800 
µl of ddH20 and 200 µl of Bio-Rad reagent. The absorbance (OD) reading of these 
samples was recorded at the wavelength of 595 nm. These values were then 
compared to a curve drawn from a standard curve (BSA curve), and 30 µg of protein 
was usually used for Western blot analysis. 
 
Protein sample preparation 
Laemmli sample (Bio-Rad) buffer added to β-mercaptoethanol is especially 
formulated for protein sample preparation. 2X Laemmli buffer was added to each 
protein sample at a ratio of 1:1 and heated on a heating block for 1-5 min.  
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Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)  
Gels were prepared in a vertical gel electrophoresis separation system (Bio-Rad). 
Resolving gel was prepared according to protein size (EBFs proteins are about 65 
kDa) containing 10% Bis/Acrylamide, 1.5 M Tris-HCl pH8.8, SDS (pH 7.2), ddH2O, 
ammonium persolfate (APS) and TEMED. The stacking gel contained 5% 
acrylamide in Tris pH6.8, SDS, APS and TEMED. Proteins were loaded into the gel 
and resolved at a constant voltage (100 V) in 1X Running Buffer. Rainbow marker 
(Amersham) was run together with proteins samples (Sambrook, Fristsch and 
Maniatis, 1989).  
 
Transfer of proteins onto a nitrocellulose membrane 
Transfer was done on nitrocellulose membrane (Amersham) which was placed 
next to the gel. The two are sandwiched between absorbent 3 MM paper and sponges 
(sponge/paper/gel/membrane/paper/sponge), and the sandwich is clamped between 
solid supports to maintain tight contact between the gel and membrane after ensuring 
no air bubbles have formed between the gel and membrane. The sandwich was then 
submerged in transfer buffer to which an electrical field was applied. The negatively-
charged proteins travel towards the positively-charged electrode, but the membrane 
stops them, binds them, and prevents them from continuing on. The transfer was 
made ON at 30 V at 4ºC. 
 
Visualization of proteins on membranes 
The morning after the membrane was washed in 1X PBST and then placed in 
blocking solution containing 5% non-fat milk (Marvel) in PBST at RT for 1 h. The 
membrane was then transferred into the blocking solution to which the primary 
antibody was added and left ON at 4°C in agitation. The morning after, the 
membrane was washed several times in PBST while agitating, 5 min or more per 
wash, to remove residual primary antibody and then placed in blocking solution to 
which the secondary antibody was added at the suggested dilution for 1-2 h at RT 
with agitation. Enhanced Chemiluminiscence reagent (ECL, Amersham) was used, 
according to manufacturer’s instructions, to detected bound antibodies. The reaction 
was detected using GEL-DOC detection machine (Bio-Rad). The camera inside the 
machine detects the chemiluminescence emanating from the membrane, transforming 
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the signal into a digital image for rapid analysis with software provided with the 
detection machine.  
2.3.6 Immunohistochemistry 
 
Specimens’ collection and preparation  
While collecting brains of different embryonic stages, the day of the plug 
formation was considered as E0.5. The day of birth was considered as P0. Pregnant 
animals were culled by cervical dislocation. Embryos and P0 animals were 
anesthetized by hypothermia prior decapitation. Adult animals were anaesthetized 
with isoflurane and subsequently perfused through the heart with PFA. Embryos and 
adult brains were dissected in cold 1X PBS and placed in PFA for 30 min up to 4 h at 
4°C depending on age.  
Coronal sections were obtained by cutting either with cryostatat (20 µm, 
embryonic tissues) or freezing microtome (40 µm, embryonic tissue for in situ 
hybridization or adult tissues). For cryostat sections, brains werecryoprotected in 
30% sucrose in 1X PBS and frozen in OCT with isopenthane prior to cutting. For 
freezing microtome sections, adult brains were cryoprotected in 30% sucrose and 
frozen directly on dry ice dust. Cryo-sections were collected onto superfrost plus 
glass slide (VWR, Leicestershire, UK), whereas freezing microtome sections were 
left free-floating and mounted at later stage. 
 
Immunoperoxidase 
Firstly, sections were treated with 0.3% H2O2 in 1X PBST for 20 min at RT 
followed by 3 washes in 1X PBST. They were subsequently, incubated in P-solution 
for 10 min at RT and in Retrival solution (BD Pharmagen, Erembodegem, Belgium) 
at 70°C for 15 min and left to cool down at RT for 10 min. Sections were then rinsed 
in 1X PBST and incubated in DAKO blocking solution for 1 h (DAKO, 
Cambridgeshire, UK), and then ON at 4°C with the primary antibody (See Table 
2.2.5) diluted in DAKO solution. The following day, sections were washed in 1X 
PBST and incubated with secondary antibodies (See Table 2.2.6) at RT for 1h. They 
were then treated with the avidin-biotin-peroxidase complex (ABC-HRP kit, dilution 
1/100, Vector) at RT for 2 h. The activity of the peroxidase was revealed using DAB 
(0.005% 3,3’diaminobenzidinetetrachloride in H2O, Sigma) as chromogen and 
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0.005% H2O2 as substrate. The reaction was stopped with 1X PBS, and sections 
dehydrated through ascending ethanol concentrations (70, 80, 95, and 100% for 1 
min each) and mounted in DPX (VWR). 
 
Immunofluorescence 
Sections were incubated in P-solution at RT for 10 min and in Retrival solution 
(BD Pharmagen) at 70°C for 15 min and then, left to cool down at RT for 10 min. 
They were subsequently rinsed in 1X PBST and incubated in DAKO blocking 
solution for 1 h (DAKO). Sections were incubated ON at 4°C with the primary 
antibody (See table 2.2.5) diluted in DAKO solution. Different primary antibodies 
raised in different hosts were used for double labeling. The following day, sections 
were washed in 1X PBST and incubated with fluorescent conjugated secondary 
antibodies at RT for 1 h (See Table 2.2.6). The secondary antibody was washed out 
with several washes with 1X PBS and tissues were treated with DAPI (4', 6-
diamidino-2-phenylindole, 2.5 µg/ml, Sigma) for 5 min. Sections were mounted in 
Mowiol (Sigma). 
 
Immunohistochemistry 
Cells were fixed in 4% PFA for 10 min and rinsed in 1X PBST. Immunoreaction 
was performed as described for tissue sections, except that coverslips were placed 
culture side up on strips of parafilm mounted on glass slides.  
 
2.3.7 Nissl Staining 
 
In order to visualize cortical layers, sections were stained with 0.025% thionin 
solution, dehydrated through ascending ethanol concentrations (70, 80, 95, and 100% 
for 1 min each) and mounted in DPX (VWR). 
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2.3.8 RNA expression analysis in organic specimens  
 
Non-radioactive in situ hybridization with labelled probes 
Brains were placed in 4% PFA/30% Sucrose for up to one week, and cut with a 
freezing microtome at 40 µm. Embryonic brains were embedded in gelatin solution 
prior freezing (20% Sucrose, 10% Porcine Gelatine in 1X PBS).  
 
Preparation of digoxygenin/fluorescin-labelled probes 
20 µg of plasmid DNA was linearised with the correct restriction enzyme, 
extracted twice with equal volumes of phenol-chloroform, precipitated with 2.5 
volumes of ethanol and 1/25 of 2 M NaCl, washed with 70% ethanol, resuspended in 
20 µl DEPC-ddH2O. 
In vitro transcription reactions were composed by: 1 µg linear template DNA, 1X 
transcription buffer (Promega), 100 µM DTT; 1X digoxigenin (DIG) or Fluorescin 
(F) RNA labelling mix (10 mM each of ATP,CTP,GTP, UTP, DIG-UTP) (Roche), 
20 units RNasin (Promega), 20 units of the appropriate RNA polymerase in 20 µl of 
DEPC-ddH2O. The mixture was incubated at 37˚C for 2 h. The RNA was 
precipitated with 2.5 volumes of ethanol and 1/25 of 2 M NaCl, washed with 70% 
ethanol, resuspended in 100 µl of DEPC-ddH2O and stored at -80˚C.  
Different probes were tested (See Table 2.2.4) 
 
First day: Hybridization 
Sections were placed in plastic slide mailers (Sigma) and fixed for 20 min in 
4%PFA, washed in 1X PBS 3 times, and placed in buffer containing 100 mM Tris-
HCl pH 8 and 50 mM EDTA pH8 added with proteinase K (PK, Roche) at 0.5 µg/ml 
for 20 min. The reaction was stopped by fixing the sections in 4% PFA for 15 min. In 
the meantime, 70 µl of probe was added in 15 ml of Hybridization solution. For two-
colours in situ, a DIG-labelled probe and F-labelled probes were added. The slides 
were either placed in hybridization solution without probes and frozen for up to six 
months at -20°C or added in the mailer with the probes and incubated at 70°C ON in 
a water bath. 
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Second day: post-hybridization washes and antibody staining 
After overnight hybridization, slides were washed in a solution containing 50% 
formamide, 2X SSC and 1% SDS at 70˚C for 45 min, 3 times.  
The slides were incubated in 1X TBST blocking solution containing 2% blocking 
reagent (Boehringer) and 10% heat-inactivated sheep serum at RT for 1 h. The 
blocking solution was then replaced with anti-digoxygenin AP-conjugated antibody 
(Fab fragments; Roche) diluted 1:5000 in blocking solution, and the incubation 
continued overnight at 4˚C (or 2 h at RT). 
 
Third day: Post-antibody washes and colour reaction 
The slides were washed 3 x 5 min in 1X TBST; then 2 x 10 min in NTMT buffer. 
Subsequently, 0.2 mM 5-bromo-4-chloro-3-indolyl-phosphate (BCIP, Roche), 0.2 
mM nitroblue tetrazolium salt (NBT, Roche) were added in NTMT buffer in order to 
stain the sections. Sections were incubated in the dark at 37˚C until the signal 
reached a satisfactory intensity (usually a few hours to overnight). The slides were 
then washed in 1X TBST to clear the background and the reaction stopped in TE 
STOP buffer and mounted with Glicergel Cytomatic (DAKO). 
 
Second colour reaction 
For the second colour reaction with fluorescein, slides were incubated in solution 
containing 50% Formamide, 2X SSC and 1% SDS at 70ºC for 15 min in order to 
remove the first antibody for 2 times. The slides were incubated in 1X TBST 
blocking solution containing 2% blocking reagent (Roche) and 10% heat-inactivated 
sheep serum for 1 h at RT. The blocking solution was then replaced with anti-
fluorescein AP-conjugated antibody (Fab fragments; Roche) diluted 1:5000 in 
blocking solution, and the incubation continued overnight at 4˚C (or 2 h at RT). The 
slides were washed 3 x 5 min in 1X TBST; then 2 x 10 min in NTMT buffer. 
Subsequently, 0.2 mM 5-bromo-4-chloro-3-indolyl-phosphate (BCIP, Roche), 0.2 
mM trinitroblue tetrazolium salt (TNT, 50 mg/ml in 85% Dimethylformamide, 
Sigma) were added in NTMT buffer in order to stain the sections. Sections were 
incubated in the dark at 37˚C until the signal reached a satisfactory intensity (usually 
a few hours to overnight). The reaction was stopped in TE STOP buffer and slides 
mounted with Glicergel Cytomatic (DAKO). 
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2.3.9 Electroporation experiments 
 
In vivo in utero electroporation in mouse embryonic brain 
The in utero electroporation is a technique that allows a quick and direct approach 
to studying the function of genes, rather than a generation of a transgenic or knock-
out line. This technique involves an electrical mediated transfer of DNA into a 
specific tissue. The electricity causes the formation of pores in cell membranes 
allowing the uptake of large molecules such as DNA (Fukuchi-Shimogori et al. 
2001; Shimogori et al. 2008).  
Time-pregnant mice (CD1 background) were anesthetized with sodium 
pentobarbital (50 µg per gram bodyweight; intraperitoneally; Sigma) and the 
abdomen was shaved. After an abdominal incision, the uterine horns were exposed 
on PBS-moistened cotton gauze. The embryos were visualized placing a flexible 
fibre cable (Leica, Japan) under the uterus, without the use of a microscope. The 
uterus was positioned between the light source and the thumb and squeezed gently in 
order to push up the embryos close to the uterine wall. DNA (1 µg) (See Table 2.2.3 
for list of plasmids used) mixed with fast green (Sigma) was then injected in one of 
the two telencephalic ventricles via a glass capillary with the use of a 
micromanipulator (KD Scientific, Japan). The target region was placed in between of 
two electrodes made of tungsten, negatively charged, and platinum, positively 
charged. A three square wave current pulse (7-10 V, 100 ms) using a pulse generator 
(A-M Systems 2100, Japan) was then passed three times at interval of 1sec. When all 
the embryos were electroporated, the uterine horns were placed back into the 
abdomen and the surgical incision was sutured. Mice were kept in a warm place until 
they were fully recovered.  
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2.4  DATA ANALYSIS 
 
2.4.1 Image analysis 
 
Bright field pictures of specimens were taken using a LEICA DM500 microscope. 
Fluorescence pictures were taken using either the same microscope or confocal 
microscope LEICA SPE-I. Different magnifications were used. Scale bars were 
adjusted every time according to magnification. 
Pictures were processed using Adobe Photoshop CS3 program. 
 
2.4.2 Data Collection and Statistical analysis 
 
Cortical thickness, white matter thickness and thalamic area were measured using 
ImageJ software. The same scale bar was set up prior to every measurement. 
Cell counts were performed using the Methamorph software. Only cells showing 
visible neurites or nuclei were considered for cytoplasmic staining and nuclear 
staining, respectively. Quantification of cell numbers was carried out at medio-
caudal levels. In embryonic stages, at E13.5, all the cells in the pallial area present in 
the section were counted, or as otherwise stated, and; at E16.5, the number of cells 
was counted in boxes that were placed over pallial regions matching control and 
mutant sections. All measurements realised in these boxes were normalised in 
number of cells per 250 µm (measured at the pial surface). In postnatal tissue, the 
number of cells was counted in boxes in regions matching control and mutant 
sections. All measurements realised in these boxes were normalised in number of 
cells per 500 µm (measured at the pial surface) and radial column.  
For all experiments, we calculated the mean of at least three independent samples. 
Data are expressed as mean ± standard error of the mean (SEM); error bars represent 
the standard error of the mean. To determine the statistical significance, we used a 
paired t test; p-value of < 0.05 was considered significant and indicated with an 
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asterisk; a p-value of < 0.01 was indicated with two asterisks and a p-value of <0.001 
with three asterisks. Statistical analysis was performed using Excel 2008 (Microsoft). 
 
86 
 
 
CHAPTER 3 
EBF2 IS EXPRESSED IN THE DEVELOPING 
CEREBRAL CORTEX, BUT LOSS OF FUNCTION 
DOES NOT LEAD TO MAJOR CORTICAL DEFECTS 
 
 
 
 
 
 
3.1  INTRODUCTION 
 
As discussed in Chapter 1, Ebf2-/- mice show multiple defects, especially in the 
cerebellum, suggesting that this gene may play important roles in brain development 
(Corradi et al. 2003; Croci et al. 2006). So far, Ebf2 expression and the effects of its 
loss of function on the development of the cerebral cortex have not been extensively 
studied. Garel and colleagues (1997) reported that Ebf2 is transiently expressed in 
post-mitotic neurons of the developing mouse forebrain, although it has always been 
difficult to establish the neuronal cell types that depend on its expression for their 
development. In this chapter, I have analysed in detail the expression of Ebf2 with 
two different approaches. Firstly, by in situ hybridisation at different developmental 
stages in wild type (wt) mice of different developmental ages; secondly, to overcome 
the early downregulation of the gene expression, Ebf2+ cell fate was followed using a 
genetic approach. Specifically, Ebf2+ cells were permanently labelled using a 
transgenic mouse line, which expressed the improved Cre recombinase gene (iCre; 
Shimshek et al. 2002) under the control of the Ebf2 promoter (Gong et al. 2003; 
Heintz, 2004). Finally, Ebf2 loss of function defects were analysed using an Ebf2-/- 
mouse line kindly provided by Dr. Giacomo G. Consalez (San Raffaele Scientific 
Institute, Milan). These studies were focused on the analysis of the anatomical and 
cellular integrity of the embryonic and adult forebrain in Ebf2-/- mice. 
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3.2  CHARACTERISATION OF Ebf2­EXPRESSING CELLS IN THE 
DEVELOPING FOREBRAIN 
 
3.2.1 Ebf2 mRNA expression in the developing mouse forebrain 
 
To identify the pattern of expression of Ebf2 during forebrain development, brains 
of mice of different embryonic stages, ranging from E10.5 to adult, were analysed 
using in situ hybridization. Ebf2 was expressed in different areas of the developing 
forebrain. In the telencephalon, it was expressed in post-mitotic regions of the 
pallium, namely septum, CH, hippocampus, neocortex (PPL/MZ) and piriform cortex 
(PCx). Expression was not detected in the pallial proliferative zone or in any of the 
subpallial domains. In the diencephalon, it was expressed in the VZ of the 
epithalamus, hypothalamus, thalamic eminences (TE) and diencephalic-telencephalic 
boundary (DTB). Expression was first detected around E10.5 in the CH, 
hippocampus and neocortical PPL (Figure 3.1, A). At E11.5 (Figure 3.1, B) and 
E12.5 (Figure 3.1, C), its expression was extended to PCx. At E13.5, Ebf2 showed 
maximum expression and it was found rostrally, in the cortical PPL and septum 
(Figure 3.2, A), while medially and caudally, it was detected in the dorsal PPL, in the 
lateral MZ and SP (as PPL splits due to the arrival of CP; Figure 3.2, B and C; Figure 
3.3, B), hippocampus, CH, PCx, epithalamus, DTB and TE (Figure 3.1, D; Figure 
3.2, B and C). The expression in the telencephalon did not show a rostro-caudal 
gradient (Figure 3.2, A-C).  
Cajal-Retzius cells, located in the cortical PPL/MZ, are believed to originate in 
the CH, septum and pallial-subpallial boundary (PSPB) (Bielle et al., 2005). The 
expression of Reelin mRNA, which is a specific marker for this cell population, 
matched the expression of Ebf2 in the cortical PPL, the CH and the septum (Figure 
3.4, A-E). Interestingly, Ebf2 expression did not coincide with Reelin mRNA 
expression in the PCx (Figure 3.4, F). The hypothesis that the Ebf2 transcription 
factor plays a role in the development of CR cells and, possibly, in the regulation of 
the Reelin pathway was extensively analysed in the Ebf2-/- mouse (see Chapter 3.3). 
Between E14.5 and E15.5, a general downregulation of the Ebf2 gene occurred in the 
PPL/MZ, hippocampus and CH (Garel et al., 1996) (Figure 3.3, C), whereas the 
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expression in the PCx, TE and DTB persisted (Figure 3.1, E and F). At P0, Ebf2 
expression was detected only in subcortical nuclei identified as zona incerta and bed 
nucleus of stria terminalis, probably derivates of DTB and TE (Figure 3.1, G).  
3.2.2 Ebf2GFPiCre line: a genetic approach to map Ebf2-derived cells 
 
In order to overcome the difficulty of tracking the lineage of Ebf2+ cells due to 
early downregulation of the gene in the telencephalon, Ebf2GFPiCre transgenic females 
were crossed with reporter animals expressing the yellow fluorescent protein under 
the control of the ubiquitous promoter Rosa 26 (R26RYFP) to permanently label Ebf2+ 
cells (Figure 3.6). The Ebf2GFPiCre transgenic line was generated in the laboratory of 
Dr. Giacomo G. Consalez by using the Bacterial Artificial Chromosome 
Recombinogenic Engineering (BAC Recombineering; Copeland et al. 2001; Lee et 
al. 2001; Testa et al. 2003), based on the homologous recombination in specific E. 
coli strains (Figure 3.5, A). In order to produce a classic transgenic mouse by this 
approach, the integration of a green fluorescent protein fused with an improved Cre 
recombinase protein (GFPiCre) construct (Badaloni A, unpublished) was targeted 
into the first coding exon of the Ebf2 locus in the BAC RP24-283N8 (Figure 3.5, A) 
(Gong et al. 2003; Heintz 2004; Chiara F. and A. Badaloni, unpublished). This BAC 
contains the Ebf2 promoter, the beginning of the Ebf2 coding sequence located in 
exon 2 and the first seven exons of the gene (for BAC specifications: Gene 
Expression Nervous System Atlas, GENSAT, www.gensat.org). The transgenic line 
obtained, coupled with a Cre-inducible reporter transgene, permits the execution of 
fate mapping experiments, allowing GFPiCre-expressing cells and their progeny to 
be indelibly labelled in vivo, even long after the Ebf2 gene is developmentally 
downregulated (Figure 3.6, A-C). Preliminary characterisation of the transgene 
expression, particularly focused on the cerebellum, compared to the endogenous 
gene expression, has demonstrated that BAC RP24-283N8 contains most of the 
regulatory sequences necessary for correct transgene expression in the brain (Chiara 
F., A. Badaloni and G. G. Consalez, unpublished).  
The expression of the GFPiCre transgene was also analysed by in situ 
hybridisation in the telencephalon and compared with the expression of the 
endogenous Ebf2 (Figure 3.5 B-E). At E13.5, GFPiCre expression matched the 
expression of Ebf2 in the CH, septum, hippocampus, cortical PPL/MZ, SP and PCx 
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(Figure 3.5, B compared to C). At E15.5, dowregulation of transgene signal occurred 
in the expected territories such as CH, septum, hippocampus and MZ, but persisted 
in the PCx (Figure 3.5, D compared to E). The expression of GFPiCre gene in the 
MZ and PCx was less intense compared to that of the endogenous gene in the same 
areas. This difference is explained by the use of in situ probes of different length as 
well as a different mRNA stability of the transgene compared to the mRNA of the 
endogenous gene (Figure 3.5, B-E). Subsequently, Ebf2GFPiCre/R26RYFP mice were 
collected at different developmental stages and the expression of YFP was followed 
from E11.5 to postnatal life. YFP immunohistochemistry at E13.5 and E16.5 
revealed that Ebf2 was expressed in pallial structures, such as neocortex, CH, 
septum, hippocampus and PCx (Figure 3.7, A and B). Moreover, YFP-expressing 
cells in the neocortex were detected in the PPL/MZ, the CP and in the SP (Figure 3.7, 
A-E). In the diencephalon, the transgene was expressed in the epithalamus, 
hypothalamus and DTB (Figure 3.7, B). No expression was detected in the thalamic 
nuclei or axons arising from this area (Figure 3.7, B). At P7, Ebf2+ cells in the 
cerebral cortex were positioned in layer I (former PPL/MZ), layer V and in the SP at 
the bottom of layer VI (Figure 3.7, E).  
Next, YFP signal was compared with the expression of different markers for 
known cortical cell populations. Only medial sections of coronally cut forebrains 
were considered.  At E11.5, YFP was expressed in the PPL and its expression 
coincided with that of p73 (Figure 3.8, A-D’). As previously described, p73 protein 
is an early specific marker for CR cells originating from the septum and CH (Meyer 
et al. 2002). Ebf2, as previously shown by in situ hibrydisation, was specifically 
expressed in CH and septum, thus explain the correlation between p73 and YFP 
signals (Figure 3.8, D’). Moreover, the expression of YFP matched the expression of 
Reelin in the PPL (Figure 3.8, E-H; H’ shows double positive cells in the circle). 
However, not all YFP+ cells did express Reelin (Figure 3.8, H’; arrowhead points to 
YFP+ cells only). Reelin is a marker of all CR cells, however it has been shown that 
its expression in the CH appears later compared to p73 protein (Meyer et al. 2002; 
Hanashima et al. 2007). Thus, YFP+/Reelin- cells were most likely derived from the 
CH, whereas YFP-/Reelin+ cells (Figure 3.8, H’; arrow points to Reelin+ cells only) 
possibly came from the PSPB, where Ebf2 was not expressed. A third marker, Calr, 
was also used to label specifically CR cells, although it has been shown that the 
polyclonal anti-Calr antibody produced by Swant and used in these experiments does 
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not recognise a subpopulation of Calr+ CR cells deriving from the septum (Bielle et 
al. 2005). At E11.5 the majority of cells were Calr+/YFP+ indicating that Ebf2 was 
expressed in CR cells as confirmed previously with other CR-specific markers 
(Figure 3.8, I-L; L’ shows double positive cells in the circle). Thus, YFP+/Calr- cells 
were derived from the septum (Figure 3.8, L’; arrowhead points to green cells only) 
and YFP-/Calr+ cells from the PSPB (Figure 3.8, L’; arrow points to red cells only). 
At E13.5, Calr labelled CR cells in the MZ (PPL is split in MZ and SP), but also SP 
cells (Figure 3.9, A-D) positioned underneath the CP at this stage (Figure 3.9, C; 
circle shows SP cells). In the MZ, YFP+/Calr+ were CR cells derived from CH 
(Figure 3.9, D; square), and in the SP layer YFP+/Calr+ represented Ebf2 expression 
in SP cells (Figure 3.9, D; circle). YFP+ cells localised in the CP and not expressing 
Calr (Figure 3.9, D), were most likely early-born pyramidal cell precursors that will 
later occupy layer IV and V in the developed neocortex (see below). Moreover, at 
E13.5 cortical migrating interneurons were also positioned in the MZ (Figure 3.9, G; 
arrow) and specifically labelled by Calb antibody. Calbindin immunoreactivity was 
not detected in YFP+ cells, suggesting that Ebf2 was not expressed in migrating 
interneurons (Figure 3.9, H; rectangle). These results were confirmed also postnatally 
(Figure 3.10). At P7, caudal sections of the cerebral cortex showed that YFP was 
expressed in CR cells, labelled with Calr antibody in layer I (Figure 3.10, C and C’). 
However, postnatally Calr was also expressed in a subpopulation of interneurons, 
which did not co-express YFP/Ebf2 (Figure 3.10, C and C’’; layer IV). Moreover, a 
small percentage of layer IV cells were also found to be YFP+, but not Calr+, 
suggesting that at caudal level Ebf2 was also expressed in pyramidal cells (Figure 
3.10, A and C). Nuclear receptor related 1 (Nurr1) (Figure 3.10, D-F’), a postnatal 
marker for SP cells, was also found to be expressed in YFP+ cells at the bottom of 
layer VI (Figure 3.10, F and F’). Moreover, YFP-expressing cells seen in the lower 
parts of developing CP at E13.5 and E16.5 (Figure 3.7, A-D; Figure 3.9, D) were 
positioned in layer V postnatally, representing a small percentage of COUP-TF 
interacting protein 2 (Ctip2)+ cells (Figure 3.10, G-I’), which is a marker of 
pyramidal cells in lower cortical layers (V-VI). Thus, Ebf2 is expressed in a 
subpopulation of layer V neurons (Figure 3.10, I and I’). 
In conclusion, during the Ebf2-expressing phase, YFP is found in the septal and 
hem-derived CR cell subpopulations and SP cells. Moreover, long after the 
disappearance of Ebf2 expression from the cortex, YFP could still be detected in 
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these cells postnatally, making the Ebf2GFPiCre mouse line an excellent tool to follow 
the fate of these two transient, but very important cortical cell populations. 
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Figure 3.1 Ebf2 expression during cortical development 
 
In situ hybridisation; coronal sections, 40 µm. 
 
A-C: At E10.5, E11.5 and E12.5, Ebf2 is detected in the PPL, CH and hippocampus 
of the telencephalon. At E11.5 and E12.5, the gene is found expressed in the PCx. 
D: At E13.5 Ebf2 is expressed in the PPL, CH, hippocampus and PCx of the pallium. 
Moreover, the gene is expressed in diencephalic regions such as the TE and Et. 
E, F: Ebf2 is dowregulated in pallial regions from E15.5. However, expression 
persists in the PCx and TE. 
G: Postnatal expression of Ebf2 is localised in Zi and BNST.  
 
BNST: bed nucleus of stria terminalis, CH: cortical hem, Et: epithalamus, MZ: 
marginal zone, H: hippocampus, PCx: pyriform cortex, PPL: preplate, TE: thalamic 
eminences, Zi: zona incerta. 
 
Scale bars: (A-D) 100 µm, (E-G) 200 µm 
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Figure 3.2 Rostro-caudal expression of Ebf2 in the developing cortex at 
E13.5 
 
In situ hybridisation; coronal sections, 40 µm. 
 
A-C: Rostral, medial and caudal sections illustrate the equally distributed expression 
of Ebf2 mRNA along the telencephalic rostro-caudal axis. In B’ high magnification of 
the developing NCx shows the specific signal in the PPL (arrow). 
 
CH: cortical hem, DTB: diencephalic-telencephalic boundary, Et: Epithalamus, H: 
hippocampus, Hy: hypothalamus, OE: olfactory epithelium, PCx: pyriform cortex, 
PPL: preplate, Sp: septum, TE: thalamic eminences. 
 
Scale bar: 200 µm (A, B and C), 50 µm (B’) 
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Figure 3.3 Higher magnification images of Ebf2 expression in the PPL and 
MZ of the developing cortex  
 
In situ hybridisation; coronal sections, 40 µm. 
 
A, B: At E12.5 and E13.5, Ebf2 is expressed in the PPL/MZ and CH. In B, PPL is 
split in the most ventral part of the pallium into MZ and SP layers by the forming 
CP. Ebf2 expression is visible in the SP layer (arrow). 
C: Ebf2 expression is dowregulated in the MZ by E15.5. 
 
CH: cortical hem, CP: cortical plate, IZ: intermediate zone, MZ: marginal zone, PPL: 
preplate, SP: subplate layer, SVZ: subventricular zone, VZ: ventricular zone. 
 
Scale bar: 100 µm 
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Figure 3.4 Expression pattern of Reelin mRNA and Ebf2 at E13.5 
 
In situ hybridisation; coronal sections, 40 µm. 
 
A, B: Reelin mRNA and Ebf2 expression match in the PPL and CH.  
C: Merge of Reelin mRNA and Ebf2 expression. Reelin mRNA (brown) and Ebf2 
(purple) signals overlap. 
D, E: Reelin mRNA and Ebf2 are both expressed in the septum. The area of the 
septum is identified by the black dots and subdivided in dorsal (d) and ventral (v) 
domains. Reelin is expressed in d and in v, whereas Ebf2 expression is confined 
mainly in d.  
F: Merge of Reelin mRNA and Ebf2 expression in the PCx shows no colocalisation in 
this area. 
 
CH: cortical hem, GE: ganglionic eminences, PCx: pyriform cortex, PPL: preplate, 
Sp: septum, St: striatum. 
 
Scale bars: (A-C) 100 µm, (D-F) 200 µm 
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Figure 3.5 Validation of the Ebf2GFPiCre transgenic mouse 
 
In situ hybridisation; coronal sections, 40 µm. 
 
A: The BAC-RP24 contains part the Ebf2 locus: the hypothetical promoter and the 
first two exons. The transgene GFPiCre was inserted through bacterial 
recombination in the second exon as shown in the figure.  
B, C: E13.5, Ebf2 and GFPiCre are expressed in the same territories.  
D, E: E15.5, GFPiCre expression is downregulated in the pallial region, as is Ebf2; 
which is still expressed in the PCx.  
 
CH: cortical hem, H: hippocampus, HOM: homology arms for recombination, MZ: 
marginal zone, PA: polyadenilation signal, PCx: pyriform cortex, PPL: preplate, SP: 
subplate. 
 
Scale bar: (B-E) 250 µm 
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Figure 3.6 Validation of the Cre-recombinase activity in Ebf2GFPiCre 
 
A: The schema shows the loxP recombination driven by the Cre recombinase at the 
Rosa26 locus. In the Ebf2GFPiCre/R26R-YFP, the activation of the Cre recombinase leads 
to the excision of the stop signal and the permanent expression of the YFP protein in 
Ebf2 expressing cells. 
B, C: Whole-mount YFP expression in Ebf2GFPiCre/R26R-YFP at E13.5 and E17.5 shows 
the activity of Cre recombinase in Ebf2+ cells. 
 
Cb: cerebellum, F: forebrain, HB: hindbrain, MB: midbrain, OB: olfactory bulb, oe: 
olfactory epithelium, YFP: yellow fluorescent protein. 
 
Scale bar: (B, C) 50 mm 
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Figure 3.7 Fate mapping of Ebf2+ cells in Ebf2GFPiCre/R26R-YFP 
 
Immunohistochemistry; coronal sections, 20 µm for the embryonic tissue and 40 µm 
for the adult tissue. 
 
A, B: Expression of YFP at E13.5 and E16.5. The transgene is expressed in the MZ, 
SP, CH, H, PCx, Sp, Am, H, Et and DTB. 
C, D: High magnification images of the pallium at E13.5 and E16.5 reveal that Ebf2 
is not only expressed in CR cells, but also in SP cells and neurons in the CP. 
E: YFP cells are found in layer I, as well as in layer V and at the bottom of layer VI 
(SP cells). 
 
Am: amygdala, CH: cortical hem, CP: cortical plate, DTB: diencephalic-
telencephalic boundary, Et: epithalamus, GE: ganglionic eminences, H: 
hippocampus, Hy: hypothalamus, IZ: intermidiate zone, MZ: marginal zone, SP: 
subplate, Sp: septum, PCx: pyriform cortex, Th: thalamus. 
 
Scale bars: (A, B, E) 100 µm, (C) 25 µm, (D) 50 µm 
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Figure 3.8 Fate mapping of Ebf2 positive cells in Ebf2GFPiCre/R26R-YFP at E11.5 
 
Immunofluorescence; coronal sections, 20 µm. 
 
A-D’: Expression of YFP perfectly matches the expression of p73, a marker of CR 
cells deriving from the CH and septum (D’). 
E-H’: YFP expression matches the expression of Reelin (H’); however, a proportion 
of cells expressing YFP did not Reelin (H’, arrowhead) and vice versa (H’, arrow). 
Cells circled are YFP+/Reelin+ (H’). 
I-L: Square show double positive cells (L’), arrowhead points to YFP+/Calr- cells 
and arrow points to YFP-/Calr+. Cells circled are YFP+/Calr+ (L’). 
 
Calr: calretinin, DAPI: 4',6-diamidino-2-phenylindole, PPL: preplate layer, VZ: 
ventricular zone, YFP: yellow fluorescent protein. 
 
Scale bar: 25 µm  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
107 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
108 
 
 
Figure 3.9 Fate mapping of Ebf2 positive cells in Ebf2GFPiCre/R26R-YFP at E13.5 
 
Immunofluorescence; coronal sections, 20 µm. 
 
A-D: After the splitting of the PPL, CR cells are positioned in the MZ, whereas SP 
cells are found in the SP layer (C, circle). YFP+/Calr+ are present in the MZ (D, 
square) and in the SP layer (D, circle). 
E-H: Expression of Calb (MZ, arrow), a marker for interneurons, does not match the 
expression of YFP (H, rectangle). 
 
Calb: calbindin, Calr: calretinin, CP: cortical plate, DAPI: 4',6-diamidino-2-
phenylindole, IZ: intermediate zone, MZ: marginal zone, SP: subplate layer, SVZ: 
subventricular zone, VZ: ventricular zone, YFP: yellow fluorescent protein.  
 
Scale bar: 50 µm  
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Figure 3.10 Fate mapping of Ebf2 positive cells in Ebf2GFPiCre/R26R-YFP at P7 
 
Immunofluorescence; coronal sections, 40 µm. 
 
A- C”: Postnatally Calr is expressed in interneurons but, some CR cells still retain 
this marker at P7. In C’ cells in the MZ co-express Calr and Ebf2. C’’, high 
magnification of Calr+ interneurons in layer IV which do not show expression of 
Ebf2. 
D- F’: Expression of Nurr1, a postnatal marker for SP cells, matches the expression 
of YFP. 
G- I’: CTIP2, a marker of layers V and VI neurons, co-localises with YFP in layer V 
(I’).  
 
Calr: calretinin, Ctip2: COUP-TF interacting protein 2, Nurr1: nuclear receptor 
related 1, YFP: yellow fluorescent protein. 
 
Scale bars: (A-I) 250 µm, (C’, C’’, F’, I’) 10 µm  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
111 
 
 
 
 
 
 
 
 
 
 
 
112 
 
3.3 ANALYSIS OF THE CORTICAL STRUCTURE AND CELLULAR 
ORGANISATION IN Ebf2­/­ MICE 
 
3.3.1 Development of the CR cell population in Ebf2-/- mice 
 
In situ hybridisation and fate mapping studies have shown that Ebf2 is expressed 
in CR cells between E10.5 and E13.5 and, as a consequence, it might play a role in 
their function. In order to study its role in the development of this cell population, I 
have analysed in Ebf2-/- mice the integrity of CR cell specification and migration in 
the neocortex. 
Cajal Retzius cell commitment was analysed through in situ hybridizations for 
transcription factors that are known to be involved in cell specification in the septum, 
PSPB and CH during early developmental stages (Figure 3.11). Dbx1, a 
homeodomain transcription factor, specifies two CR cell subpopulations originating 
from the septum and the PSPB. Its expression was found in the expected territories in 
Ebf2-/- mice. However, Dbx1 signal in the septum of Ebf2-/- was reduced, whereas, it 
was augmented in the PSPB compared to wt controls (Figure 3.11, A compared to B, 
septum; C compared D, PSPB). Wnt3a is, instead, specifically expressed in the CH. 
Its expression was found in the expected territories of Ebf2-/- mice and it looked 
expanded compared to wt controls (Figure 3.11, E compared F). Foxg1 is involved in 
the specification of the telencephalon, and promotes self-renewal of neuronal 
precursors antagonising their neuronal differentiation (Martynoga et al., 2005; 
Hanashima et al., 2004). In fact, loss of function studies show that lack of Foxg1 
leads to abnormal differentiation of early-born cortical progenitors that adopt CR cell 
fate (Hanashima et al. 2004). This consequently causes an increased production of 
Reelin that alters the expression of Ebf2.However, its expression was found to be 
normal in Ebf2-/- mice (Figure 3.11, K compared to L). 
I have also analaysed the expression of Reelin mRNA, as it is a secreted factor, 
which plays a pivotal role in the specification of all the CR cell subpopulations. Its 
expression was found diminished in the septum of Ebf2-/- mice compared to wt 
controls (Figure 3.11, G compared to H). Interestingly, a stronger signal of Reelin 
mRNA was detected in the CH of Ebf2-/- mice compared to wt controls (Figure 3.11, I 
compared to J). Moreover, it was expressed less in the dorsal PPL and more in the 
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lateral PPL of Ebf2-/- mice (Figure 3.11, J; arrow and arrowhead, respectively) 
compared to wt controls (Figure 3.11, I; arrow and arrowhead, respectively). 
Migration was analysed by tracking the position of CR cells using a combination 
of different CR subpopulation markers such as Calr, Reelin and p73. Firstly, at 
E13.5, Calr+ cells were found in the MZ (Figure 3.12, B’ and C’) and CH (Figure 
3.12, B and C). Cell counts revealed a significant reduction in the number of Calr+ 
cells in the MZ of Ebf2-/- mice compared to wt controls (Figure 3.12, A, B’, C’ and J; 
Ebf2+/+ 42±2, Ebf2-/- 31±2; n=6; p< 0.001). At the same time, more Calr+ cells were 
found in the CH of mutant animals, suggesting a possible problem in the migration of 
CR cells from the CH into the cortex (Figure 3.12, A, B, C and J; Ebf2+/+ 44±3, Ebf2-
/- 73±3; n=6; p< 0.001). However, Calr alone is not a good marker of CR cells, as it 
recognises other cell types in the MZ such as SP cells. Reelin+ and p73+ cells were 
also examined. Reelin cell number was found to be significantly reduced in the MZ 
and, on the contrary, increased in the CH and septum of Ebf2-/- mice (Figure 3.12, D-
F’’ and K; MZ, Ebf2+/+ 88±2, Ebf2-/- 79±2; n=6; p<0.01; CH, Ebf2+/+ 68±1, Ebf2-/- 
90±1; n=6; p<0.05; Sp, Ebf2+/+ 64±1, Ebf2-/- 86±4; n=6; p<0.05). Six mutants 
embryos were considered and showed significant differences in Calr and Reelin 
counts when compared to the respective wt littermates. 
Interestingly, p73 cell number was unchanged in the MZ and in the CH, but it was 
slightly increased in the septum of Ebf2-/- mice compared to wt controls (Figure 3.12, 
G-I’’ and L; MZ, Ebf2+/+ 49±2, Ebf2-/- 50±2; n=3; CH, Ebf2+/+ 126±1, Ebf2-/- 120±1; 
n=3; Sp, Ebf2+/+ 97±4, Ebf2-/- 118±2; n=3; p<0.05). However, this may be explained 
by the use of unreliable antibody. 
CR cell migration in pallial regions is terminated by E16.5, and these cells are 
positioned in the MZ. Calretinin, Reelin and p73 immunohistochemistry, labelling 
almost exclusively CR cells in the MZ, did not show any reduction in CR cell 
numbers in Ebf2-/- animals (Figure 3.13 A-C; Calr, Ebf2+/+ 21±3, Ebf2-/- 23±2; n=3; 
Reelin, Ebf2+/+ 70±3, Ebf2-/- 65±4; n=3; p73, Ebf2+/+ 44±2, Ebf2-/- 46±2; n=3).  
In conclusion, it appears that Ebf2 is not involved in CR cell commitment, but in 
their early migration. However, the rescue of the migration defect at later stages of 
development, suggests that this gene alone is not necessary in regulating CR cell 
migration and function. 
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Figure 3.11 CR cell fate determination 
 
In situ hybridisation; E12.5 forebrain, coronal section, 40 µm. 
 
A-D: Dbx1 expression in the septum and PSPB (Ebf2 is not expressed in this region). 
E, F: Wnt3a expression in the CH. 
G-J: Reelin mRNA expression in the CH/PPL and septum, respectively. Arrow 
indicates dorsal PPL and arrowhead points to lateral PPL. 
K, L: Foxg1 expression in cortical progenitors of the NCx. 
 
CH: cortical hem, Dbx: developing brain homeobox 1, Foxg1: forkhead box G1, 
NCx: neocortex, Sp: septum, PPL: preplate, PSPB: pallial subpallial boundary, 
Wnt3a: wingless type 3a. 
 
Scale bar: 100 µm 
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Figure 3.12 CR cell migration  
 
Immunohistochemistry; E13.5, coronal sections, 20 µm. 
 
A, D and G: Schemas indicating the rostro-medial expression areas of Calr, Reelin 
and p73, respectively. 
B-C’; E-F” and H-I”: Expression of Calr, Reelin and p73, respectively, in the Sp (E 
and F, Reelin; H and I, p73), CH (B and C, Calr; E’ and F’, Reelin; H’ and I’, p73) 
MZ (B’ and C’, Calr; E’’ and F’’, Reelin; H’’ and I’’, p73) of Ebf2+/+ and Ebf2-/-. 
Arrows point in each of Calr and Reelin samples to some visible cells that were 
counted. 
J, K and L: Counts of Calr, Reelin and p73, labelled cells in the MZ, CH and Sp. 
 
Calr: calretinin, CH: cortical hem, MZ: marginal zone, Sp: septum. 
Scale bars: (B’, C’, E’’, F’’, H’’, I’’) 50 µm, (B, C, E, E’, F, F’, H, H’, I, I’) 25 µm 
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Figure 3.13 E16.5 CR cell migration 
A-C: Calr, Reelin and p73 cell counts in the MZ.  
 
MZ: marginal zone. 
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3.3.2 Analysis of the cytoarchitecture of the cerebral cortex of Ebf2-/- 
mice  
 
As previously described, Ebf2-/- adult mice appeared smaller compared to wt 
littermate controls (Corradi et al., 2003; Croci et al., 2006). The overall size and 
weight of the mutant brains were reduced by approximately 20% compared to wt 
brains (Figure 3.14, A-C; Ebf2+/+ 0.525±0.008, Ebf2-/- 0.425±0.02; n=10; p<0.001). 
This may be due to the dramatic reduction of the cerebellum, as previously described 
by Croci and colleagues (2007). The mutant telencephalon did not show any gross 
defects in the structure (Figure 3.14, A compared to B). 
 As Ebf2-/- mice showed a delayed migration of CR cells at the early stages of 
development, I have evaluated the presence of phenotypical defects in Ebf2-/- cortex 
by analysing the cortical layer organization postnatally (Figure 3.15). It is known that 
loss of Reln leads to failure of PPL splitting with the formation of a ‘superplate’ layer 
and misplaced CP layers in reeler mutants (Caviness and Sidman, 1973). However, it 
has been shown that ablation of CH or CR cells loss does not necessary lead to major 
cortical defects, indicating that even a small amount of Reelin may be sufficient for 
the formation of the correct cortical lamination (Yoshida et al., 2006). 
Postnatally, cortical six layer organisation was maintained in Ebf2-/- mutants 
(Figure 3.15, A compared to B). Moreover, immunostaining with specific markers 
for upper, Cux1, and lower cortical layers, Ctip2, showed that these were not 
inverted in mutants compared to controls (Figure 3.15, C-F). Although the number of 
Ctip2 and Cux1 positive cells were unchanged in Ebf2-/- mice (Figure 3.15, G and H; 
Ctip2, Ebf2+/+ 446±22, Ebf2-/- 412±34; n=3; Cux1, Ebf2+/+ 1474±72, Ebf2-/- 
1346±65; n=3), an overall reduction of 10% of the cortical thickness along the entire 
rostro-caudal length of the telencephalon was observed in Ebf2-/- (Figure 3.14, D-F; 
Ebf2+/+ 970±11, Ebf2-/- 935±12; n=10; p<0.01). White matter thickness was 
unchanged in Ebf2-/- mutants (Figure 3.14, D-F; Ebf2+/+ 180±4, Ebf2-/- 176±3; n=10). 
Interestingly, the total thalamo-hypothalamic area was found significantly reduced in 
Ebf2-/- mice compared to wt controls (Figure 3.14, G- I; Ebf2+/+ 6.17±0.1, Ebf2-/- 
5.22±0.1; n=10; p<0.001). 
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Figure 3.14 Ebf2-/- cortices are reduced in size compared to littermate controls 
 
Nissl staining, coronal sections, 40 µm. 
 
A-C: The brain weight of Ebf2-/- mice was significantly reduced (C, p<0.001).  
D-F: Only the cortical, but not the white matter thickness, was found to be reduced in 
Ebf2-/- mice (p<0.01). 
G-I: Black dots in G and H outline the thalamic and hypothalamic areas which are 
reduced in Ebf2-/- mice (I). 
 
Cb: cerebellum, cc: corpus callosum, H: hippocampus, Hb: habenula, Hy: 
hypothalamus, LV: lateral ventricle, NCx: neocortex, OB: olfactory bulb, SC: spinal 
cord, St: striatum, TC: telencephalon, Th: thalamus, wm: white matter.  
 
Scale bars: (A, B) 50 mm, (D, E, G, H) 500 µm  
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Figure 3.15 Postnatal (adult) cortical layer organisation in Ebf2 -/- mutants 
 
Immunohistochemistry and Nissl staining, coronal sections, 40 µm. 
 
A, B: The adult Ebf2 -/- mouse cortex is a six-layer structure, similar to control 
brains. 
C-F: Layers in Ebf2 -/- mutants are correctly positioned, as confirmed by Ctip2 and 
Cux1 staining. Despite the reduction in cortical thickness in Ebf2 -/- mice, cell 
number in upper and lower cortical layers is not reduced (G and H, respectively). 
 
Ctip2: COUP-TF interacting protein 1, Cux1: Cut-like homeobox 1. 
 
Scale bar: 100 µm. 
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3.3.3 Interneuron migration and organisation is not affected in Ebf2 -/- 
mice 
 
Ebf2 is expressed during embryonic development in the PPL and MZ. These 
layers are used as a route for migration/settlement of three different cell populations, 
namely CR cells, SP cells and interneurons. In Paragraph 3.2.2 (Figure 3.9), I have 
shown that Ebf2 is expressed in CR cells and SP cells, but not in interneurons. 
However, interneuron development and migration was analysed in Ebf2-/- mutants in 
order to exclude non-cell autonomous effects of Ebf2 loss of function on this cell 
population. 
 Calbindin, a calcium binding protein is expressed in cortical interneurons during 
embryonic development and adult life. It has been used as a specific interneuron 
marker, particularly in embryonic stages (Anderson et al. 1997; Andrews et al. 
2006). At E13.5 and E16.5, immmunohistochemistry experiments did not reveal a 
reduction of Calb expression or impaired migration of Calb+ cells in Ebf2-/- animals 
in the cortex (Figure 3.16, E16.5, C, D and F; Ebf2+/+ 155±6, Ebf2-/- 152±7; n=3). 
Specifically at E13.5, Calb+ cells were found in the MZ and IZ, and they were 
counted in two adjacent (a and b) regions in order to exclude a possible delay in the 
migration of interneurons from the GE (Figure 3.16, A, B and E; a: MZ, Ebf2+/+ 
101±3, Ebf2-/- 109±3; IZ, Ebf2+/+ 78±3, Ebf2-/- 76±3; b: MZ, Ebf2+/+ 44±2, Ebf2-/- 
38±3; IZ, Ebf2+/+ 27±3, Ebf2-/- 25±1; n=6) 
Postnatally, interneurons, labelled with antibodies to Calb, Calr and Pv, which 
together stain the vast majority of the adult GABAergic interneurons, did not show 
any abnormalities in laminar position and number in Ebf2-/- mice compare to wt 
controls (Figure 3.17; Calb, Ebf2+/+ 77±2, Ebf2-/- 82±3; Calr, Ebf2+/+ 95±3, Ebf2-/- 
89±3; b: Pv, Ebf2+/+ 231±9, Ebf2-/- 238±10; n=3).  
 
 
 
 
 
 
 
126 
 
Figure 3.16 Interneuron migration is not affected in Ebf2 -/- mutants  
 
Immunohistochemistry and Nissl staining, coronal sections, 20 µm. 
 
A-F: During embryonic life, Calb+ cells are found migrating in the MZ and IZ. There 
are no significant changes in their number in Ebf2 -/- mice compared to wt controls. 
Arrows point to visible cells. 
At E13.5, cells were counted in two different areas, a) at the PSPB, and b) in the 
NCx. 
 
Calb: calbindin, CP: cortical plate, IZ: intermediate zone, MZ: marginal zone, SP: 
subplate layer. 
 
Scale bars: 100 µm 
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Figure 3.17 Postnatal settlement and numbers of interneurons are not 
affected in Ebf2 -/- mutants 
 
Immunohistochemistry and Nissl staining; coronal sections, 40 µm. 
 
A-I: Three different markers, Calb, Calr and Pv, were used in order to stain the vast 
majority of adult cortical interneurons. Cell counts of the three different populations 
did not reveal significant changes between Ebf2 -/- mice and wt littermates. 
 
Calb: calbindin, Calr: calretinin, Pv: paravalbumin. 
 
Scale bar: 100 µm 
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3.3.4 Analysis of SP cells and thalamocortical connections in Ebf2-/- 
mice 
 
Subplate cells, as described in Chapter 1, play a pivotal role during development 
in guiding the formation of thalamic connections to the correct areas of the cerebral 
cortex. I have shown and confirmed in the Ebf2GFPiCRE line co-expression of Calr or 
Nurr1 with Ebf2 in the SP layer during embryonic and postnatal development. At 
E16.5, SP layer was fully developed, and cells were clearly visible and labelled with 
Calr. There were no significant changes detected in the cell number in Ebf2-/- mice 
compared to wt littermate controls (Figure 3.18; Ebf2+/+ 45±3, Ebf2-/- 41±2; n=3). 
Postnatally, the number of Nurr1 positive cells was counted in mutants and compared 
to wt animals. Changes in position or cell number were not detected in Ebf2-/- mice 
(Figure 3.19; Ebf2+/+ 104±12, Ebf2-/- 103±11; n=3). 
In order to exclude thalamic defects, suggested also by the thalamic area reduction 
seen in mutants, the correct formation of the barrel cortex was analysed. The barrel 
cortex refers to dark-stained regions found in layer IV of the somatosensory cortex 
that receive inputs from the thalamus. Barrels are found in rodents and other species 
that specifically rely on whiskers for proprioception. Inputs from the thalamus 
carrying information from a given whisker terminate of layer IV forming 
anatomically distinguishable areas (barrels), which are separated from each other by 
septa. Neurons within the layer IV barrel cortex directly code for whisker 
displacement. Postnatally, barrels were visualized by DAPI and cytochrome oxidase 
(CO) staining in mutants and control animals (Figure 3.20). In mutants, barrels are 
clearly visible in the DAPI and CO staining (Figure 3.20, A compared to B is a DAPI 
staining; C compared to D detectes the CO activity; squares and arrows delineate the 
barrels in C and D), and they are organised with the expected structure (the septa are 
clearly visible between barrels). 
 
 
 
 
 
 
131 
 
Figure 3.18 Embryonic SP cells counts 
 
Immunohistochemistry; coronal sections, 20 µm. 
 
A, B: Calr+ cells are clearly visible in the SP layer. 
C: Cell counts do not reveal significant changes in Ebf2-/- compared to wt controls. 
 
Calr: calretinin, SP: subplate. 
 
Scale bar: 100 µm 
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Figure 3.19 Postnatal SP cells counts 
 
Immunohistochemistry; coronal sections, 40 µm. 
 
A, B: Nurr1 is a specific marker of postnatal SP cells. 
C: Cell counts do not reveal significant changes in Ebf2-/- mice compared to wt 
controls. 
 
Nurr1: nuclear related receptor 1, SP: subplate. 
 
Scale bar: 150 µm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
134 
 
 
 
 
 
 
 
 
 
 
 
 
135 
 
Figure 3.20 Barrel cortex in Ebf2-/- mice 
  
DAPI and CO staining; coronal sections, 40 µm. 
 
A, B: DAPI staining show barrel columns, delimited by the square, in wt and mutant 
slice. 
C, D: Pattern of CO activity in layer IV of wt controls and Ebf2 mutants. High 
enzymatic activity characterise the darker areas, called barrels, delimited by black 
square. The barrels are separated by low metabolic activity regions called septa. 
 
CO: cytochrome oxydase, DAPI: 4',6-diamidino-2-phenylindole. 
 
Scale bars: 100 µm 
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3.4 DISCUSSION 
 
3.4.1 Ebf2 is expressed in CR cells and other cortical cell populations 
during forebrain development 
 
In this chapter, I have shown that Ebf2 is expressed in the developing mouse 
forebrain between E10.5 and P0. In the telencephalon, it is expressed in post-mitotic 
regions of the pallium, such as septum (rostrally), CH (caudally), PPL/MZ (along the 
entire rostro-caudal axis) and PCx until E14.5. In the diencephalon, it is expressed in 
the epithalamus, hypothalamus and TE. The expression of Ebf2 matches the 
expression of Reelin in CH, PPL/MZ, dorsal part of the septum but, interestingly, not 
in PSPB/PCx. Reelin, commonly used to label CR cells, is an important secreted 
factor that plays a pivotal role in cortical layer organisation. Thus, this data have 
shown a strong correlation between Ebf2 expression and position of CR cells. 
However, due to the early cortical downregulation of the gene and the absence of an 
efficient antibody able to discriminate EBF proteins, the tracking of the Ebf2 protein 
expression was so far difficult. Using as genetic approach the mouse transgenic line 
Ebf2GFPiCre/R26R-YFP (Chiara F, Badaloni A and Consalez G, unpublished data), I was 
able for the first time to effectively and permanently labelled Ebf2 expressing cells in 
the forebrain. In fact, I have shown that Ebf2 is expressed in CR cells that have most 
likely originated from the septum and CH. Three main sites of origin of CR cells 
have been proposed, namely septum, CH and PSPB; and Ebf2 is expressed in all but 
one (PSPB). Three different markers, widely used for labelling CR cells, such as 
Reelin, Calr and p73, have been used in this chapter to follow the expression of Ebf2 
in CR cells. The expression of these markers was compared with the expression of 
YFP of caudo-medial coronal sections only, containing mostly CH-derived CR cells 
(Bielle et al., 2005; Yoshida et al., 2006; Griveau et al., 2010). Calretinin and Reelin 
have shown a partial match with Ebf2 expression, and this is explained as follows. 
Calretinin labels CR cells derived from CH and PSPB, but not from septum. Thus, 
Calr+/Ebf2+ cells come from the septum and Calr+/Ebf2- cells from the PSPB. Reelin 
is a broad marker of CR cells originating from septum, CH and PSPB. Thus, 
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Reelin+/Ebf2- cells come from the PSPB. p73 is a specific marker of CR cells derived 
from the septum and CH; and  p73 completely co-localised with Ebf2 in CH-derived 
cells and partially in septum-derived cells as Ebf2 is detected only dorsally in this 
area.  
A recent paper by the Portera-Cailliau group (Chowdhury et al. 2010), using a 
similar transgenic line expressing only the GFP protein under the control of the Ebf2 
promoter, has shown similar results. In contrast with my data, they showed a 
persistent postnatal expression of Ebf2 in PPL/MZ cells based only on the study of 
the mere transgenic expression of the protein GFP. However, it is know that GFP is a 
stable protein, which is expressed much longer after its mRNA production has ceased 
(Jusuf et al. 2009). In fact, my data have indicated a downregulation of the Ebf2 
promoter activity confirmed in both wt animals and the transgenic line Ebf2GFPiCre by 
the lack of mRNA expression after E14.5 in pallial structures. The permanent 
labelling of Ebf2-expressing cells was achieved only by crossing the transgenic line 
with the reporter line R26RYFP allowing a permanent modification of the Rosa26 
locus in Ebf2+ cells by the Cre recombinase. Even though the these two transgenic 
lines share similarities, analysis of the cell fate of Ebf2+ cells is only possible by 
using the Ebf2GFPiCre mice described in this thesis. 
Ebf2 is also expressed in SP cells, as confirmed by the embryonic marker Calr and 
the postnatal marker Nurr1 (Hoerder-Suabedissen et al. 2009), and by a 
subpopulation of layer V pyramidal neurons. Ebf2 expression in subpallial structures 
(identified in the adult as BNST and ZI) as well as in diencephalic areas was not 
analysed in detail, as this study focused primarily on cerebral cortex development. 
 
3.4.2 Early CR cell migration defect is rescued at later stages of 
development in Ebf2-/-mice 
 
Cajal-Retzius cell migration was affected during early development in Ebf2-/- mice. 
At E13.5 the number of Calr+ and Reelin+ cells was significantly reduced in the 
PPL/MZ of Ebf2-/- animals compared to wt controls, whereas the number of Calr+ 
and Reelin+ cells was increased in the septum and CH of mutant animals. At E16.5, 
the number of Calr+ and Reelin+ cells in the MZ of Ebf2-/- was unchanged compared 
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to control littermates. Borrell and Marin (2006) show that the meningeal membranes 
are a necessary and sufficient substrate for the tangential migration of hem-derived 
CR cells in a CXCR4-dependent manner. My data suggest a delayed migration of CR 
cells that seem to be retained for longer in the septum and the CH. Thus, Ebf2 may 
control CR cell migration targeting directly the expression of CXCR4. Future 
experiments should analyse in Ebf2-/- the integrity of the expression of CXCR4 
receptor and the ability of CR cells to respond to its ligand SDF-1. However, the 
migratory defect is rescued at later stages of development due most likely to a 
compensatory expression of other genes involved in similar functions. Reelin+ cell 
number defects are in accordance with the changes in the expression of its mRNA in 
the PPL/MZ and CH. In fact, Reelin mRNA was expressed more in the CH and less in 
the dorsal PPL of Ebf2-/- mice compared to wt controls suggesting a delay in the 
migration of CR cells. Interestingly, more signal was, instead, detected in the lateral 
PPL indicating a possible increase in the migration of CR cells from other sources, 
such as the PSPB (Griveau et al, 2010). This could explain as well the changes 
detected in the expression of Dbx1 and Wnt3a in the septum/PSPB and CH, 
respectively, at early developmental stages. However, as only caudo-medial coronal 
sections were considered, the migration defect was probably CH specific, whereas 
the changes detected in the other areas were due to rescue mechanisms by a pallial 
redistribution of other CR cell subpopulations (Yoshida et al., 2006; Griveau et al, 
2010). This hypothesis will be explained in detail in Chapter 4 (see Discussion 
4.4.2). Cortical layer organisation was not affected in Ebf2-/- by the migratory delay 
of CR cells. Interestingly, the number of p73+ cells in the MZ and CH in Ebf2-/- mice 
remain unaltered, whereas a significant increase in p73 cells was detected only in the 
septum. However, this may be explained by the use of unreliable antibody. 
 
3.4.3 Subplate cells develop normally in Ebf2-/- 
 
Subplate neurons are the first cortical neurons to send corticofugal projections, 
thus pioneering the thalamocortical connections (McConnell et al. 1994). 
Furthermore, a large number of cortical afferents reside in the SP layer and form 
transient synaptic interactions with SP cells. For thalamic fibers, this is crucial for the 
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entry of axons to the overlying cortex and their later segregation into layer IV. There 
is general agreement that most SP cells disappear during postnatal stages by cell 
death, a few remaining in the adult white matter as interstitial neurons. I have shown 
that Ebf2 is expressed in SP cells during development. However, Calr in embryos 
and Nurr1 in postnatal animals did not reveal significant changes in cell counts or 
localisation of SP cells in Ebf2-/-. 
Thalamo-cortical axon development in the cortex was not affected in Ebf2-/- as 
revealed by the analysis of the barrel cortex organisation in Ebf2-/-. Together, these 
data suggest that Ebf2 alone may not be required for the correct development of the 
SP cell population. 
 
3.4.4 Telencephalic organisation is not affected in adult Ebf2-/-  
 
The overall brain size and the cortical thickness was reduced by approximately 
20% in Ebf2-/- mice, but counts of pyramidal cells and interneurons as well as Nissl 
staining analysis did not reveal significant changes in the cell number or distribution. 
However, the absence of misplaced cortical cells as a result of migratory defects may 
not be completely excluded. In fact, the techniques used in this thesis were not 
sensitive enough to detect small changes in the position for example of layer IV or V 
pyramidal cells that express Ebf2. Bromodeoxiurydine (BrdU) injections at different 
developmental time points and analysis of the position of the BrdU labelled cells in 
the adult cortex will help to clarify this hypothesis.  
The overall reduction of the brain and cortical thickness size could be explained 
by the fact that Ebf2-/- mice are smaller compared to wt littermates, so that the organs 
adapt to the size of the mutant animal.  A bone mass reduction and an increased 
number of osteoclasts were also detected. Thus, bone development defects could 
influence the final size of Ebf2-/- mice (Kieslinger et al. 2005). Moreover, Ebf2-/- 
mice show hypogonadotropic hypogonadism as a consequence of GnRH neuron 
death during development. This results in decrease or lack of gonadal stimulating 
pituitary hormones: follicle stimulating hormone (FSH) and luteinizing hormone 
(LH). 
Failure of the hypothalamus-gonads negative feedback regulation could lead to 
reduce body mass.  
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3.4.5 Conclusions 
 
The mild defects observed in Ebf2-/- mice prompted me to analyse the expression 
and function in cerebral cortex development of other members of the COE family, 
Ebf1 and Ebf3. In fact, previous studies suggest that Ebf1 and Ebf3 are expressed in 
overlapping territories of the developing forebrain and may play a redundant role. 
This hypothesis was analysed in Chapter 4. 
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CHAPTER 4 
A REDUNDANT FUNCTION OF EBF FACTORS IN 
THE COMMITMENT AND MIGRATION OF CR CELLS 
 
 
 
 
 
 
4.1  INTRODUCTION 
 
As presented in Chapter 3, I found that Ebf2 was transiently expressed in different 
areas of the developing forebrain. Interestingly, in addition to its expression in the 
PPL/MZ of the telencephalon, it was found in the septum and CH, known sites for 
the origin of CR cells. Fate mapping studies on Ebf2 expressing cells, using the 
transgenic mouse line Ebf2GFPiCre/R26R-YFP, have revealed that the gene is specifically 
expressed in the CH and septum-derived CR cell subpopulations, SP cells and a 
subpopulation of layer V pyramidal neurons. However, the analysis of the 
development and functions of these cell groups in Ebf2-/- mice did not show any 
abnormalities, with the exception of a transitory delay in the migration of CR cells 
from the CH and septum into the PPL/MZ. The mild defects observed in the 
telencephalon of Ebf2-/- mice suggest that other factors expressed in the 
telencephalon may compensate its loss of function. Previous studies have implied 
that Ebf1 and Ebf3 are expressed in overlapping territories of the developing 
forebrain and may play redundant roles (Garel et al. 1997). In fact, it has been shown 
that the mouse EBF proteins show 75% identity. EBF1 and EBF3 are the most 
similar, whereas EBF2 differs at the carboxy-terminal domain used to interact with 
other proteins (Crozatier and Vicent, 1999; Dubois and Vicent, 2001). For instance, 
the olfactory epithelium of Ebf1-/- mice is reported to develop normally due to the 
redundant function of Ebf3 (Garel et al. 1997; 1999). In contrast, Ebf2 plays a 
specific function in this territory. In fact, the olfactory epithelium of Ebf2-/- mice 
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gives rise to defective GnRH neurons, which are unable to migrate towards their 
positions in the hypothalamus. Thus, these factors could very well compensate for 
each other during telencephalic development.  
In order to test this hypothesis, I have analysed in this chapter the expression of 
Ebf1 and Ebf3 in the telencephalon of wt and Ebf2-/- mice. According to their 
patterns of expression, I have tested in vitro and in vivo whether the overexpression 
or downregulation of the EBFs may affect CR cell specification and migration. 
 
 
4.2  COE MEMBERS Ebf1 AND Ebf3 ARE EXPRESSED IN THE 
DEVELOPING TELENCEPHALON IN Ebf2+ TERRITORIES 
 
4.2.1 Analysis of Ebf1 and Ebf3 mRNA expression in the developing 
mouse telencephalon 
 
Previous studies by Garel and colleagues (Garel et al. 1997) have reported that 
Ebf1 and Ebf3 are transiently expressed together with Ebf2 during forebrain 
development. As mild defects were observed in the migration of CR cells at early 
embryonic stages (see Chapter 3), I have focused the analysis of their expression in 
the cerebral cortex. To identify the pattern of expression of Ebf1 and Ebf3 in the 
pallium, brains of mice at different ages were analysed using in situ hybridisation. 
Ebf1 and Ebf3 were detected from E10.5 to E15.5, when they were downregulated in 
a similar fashion as it was previously reported in Chapter 3 for Ebf2 (Chapter 3.2.1). 
At E13.5, Ebf1 and Ebf3 expression was similar to that of Ebf2 in the CH and PPL 
(Figure 4.1, A and C compared to B). Additionally, Ebf3 was detected in the PSPB 
(Figure 4.1, C’), which is one of the site of origin of CR cells. In the septum, Ebf3 
was expressed strongly dorso-ventrally (Figure 4.1, F; rectangle), Ebf2 was detected 
just in the most dorsal area (Figure 4.1, E; rectangle), whereas Ebf1 was weakly 
expressed dorso-ventrally (Figure 4.1, D; rectangle). At E15.5, Ebf1 expression was 
downregulated in the pallium (Figure 4.2, A) similar to Ebf2 (Figure 4.2, B), whereas 
Ebf3 was still detected in the CH and MZ (Figure 4.2, C; arrow and arrowhead, 
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respectively). Ebf3 expression persisted in these areas also after birth (data not 
shown). 
4.2.2 Ebf1 and Ebf3 expression in Ebf2-/- mice 
Ebf1 and Ebf3 expression was also analysed in Ebf2-/- mice in order to assess 
whether its loss of function could lead to differences in the mRNA expression of 
these two factors. At E13.3, in situ hybridisation experiments showed that Ebf1 and 
Ebf3 were expressed in the CH and PPL (Figure 4.3, A and E compared to B and F, 
respectively). However, their expression was found diminished in the septum of 
Ebf2-/- mice compared to wt controls (Figure 4.3, C and G compared to D and H, 
respectively). Furthermore, Ebf3 expression in the PSPB was increased in Ebf2-/- 
mice compared to wt controls (Figure 4.3, G compared to H). 
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Figure 4.1 Ebfs expression in the cortex at E13.5 
 
In situ hybridisation; coronal sections, 40 µm. 
 
A-C: Ebf1, Ebf2 and Ebf3 expression in PPL and CH. Ebf3 is also detected in PSPB 
(C’)  
D-F: Ebf1, Ebf2 and Ebf3 expression in the septum. Rectangle divides the area in 
dorsal (d) and ventral (v) 
 
CH: cortical hem, PCx: pyriform cortex, PPL: preplate, PSPB: pallial subpallial 
boundary, Sp: septum, St: striatum. 
 
Scale bars: 100 µm 
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Figure 4.2 Ebfs expression in the cortex at E15.5 
 
In situ hybridisation; coronal sections, 40 µm. 
 
A, B: Ebf1 and Ebf2 are downregulated in the MZ and CH  
C: Ebf3 is detected in the CH (arrow) and in MZ (arrowhead) 
 
CH: cortical hem, MZ: marginal zone, St: striatum. 
 
Scale bars: 200 µm 
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Figure 4.3 Ebf1 and Ebf3 expression in the cortex of Ebf2-/- mice at E13.5 
In situ hybridisation; coronal sections, 40 µm. 
 
A-F: Ebf1 and Ebf3 are detected in the PPL and CH in wt and in Ebf2-/- mice 
C-H: Ebf1 and Ebf3 are expressed in the septum of wt and in Ebf2-/- mice. However, 
expression in Ebf2-/- mice is diminished compared to wt controls, whereas Ebf3 
expression is augmented in the PSPB of Ebf2-/- mice. 
 
CH: cortical hem, Sp: septum, PPL: preplate. 
 
Scale bar: 100 µm 
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4.3  OVEREXPRESSION AND DOWNREGULATION OF EBFs 
AFFECT CELL MIGRATION 
 
In situ hybridisation analyses revealed that Ebfs were transiently expressed in the 
same pallial structure, specifically in the CH and septum, and PPL/MZ, the site of 
origin and migration of CR cells, respectively. Thus, they could act together in 
regulating CR cell development. To test this hypothesis, I have used two different 
approaches, overexpression and downregulation of single or multiple Ebf genes in 
vitro and in vivo. The plasmids used in the following experiments were kindly 
provided by Dr Giacomo G. Consalez. 
 
4.3.1 In vitro validation of overexpressing and silencing plasmids  
 
The specificity of the Ebf-flag and short hairpin (sh) Ebf plasmids were tested in 
vitro in COS cells, which do not express any of the COE genes (data not shown). 
Confluent COS cells were transfected with Ebf1/2/3-flag separately and cultured for 
24 h. Cells were split and subsequently transfected with different combinations of 
shEbfs as follows: 
Non-transfencted COS cells were used as negative controls and indicated as 
Blank. 
After 72 h past the second transfection with the shEbfs, cells were collected and 
proteins extracted to be used for Western blot analysis. Proteins were quantified and 
the same amount was used for each sample (Figure 4.4, 1, 2 and 3; α-tubulin shows 
2. Ebf2-flag +  
a) shEbf1 
b) shEbf2 
c) shEbf3 
d) shEbf1-2-3 
e) shMock 
 
1. Ebf1-flag +  
a) shEbf1 
b) shEbf2 
c) shEbf3 
d) shEbf1-2-3 
e) shMock 
 
3. Ebf3-flag +  
a) shEbf1 
b) shEbf2 
c) shEbf3 
d) shEbf1-2-3 
e) shMock 
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protein concentration). The intensity of the shMock (containing scattered RNA, used 
as positive control) band on the blot was used as reference.  
A significant reduction in the expression of the EBF proteins compared to shMock 
transfected cells was observed in the following samples (Figure 4.4, 1, 2 and 3; red 
arrows): 
• Ebf1-flag transfected COS cells and treated with shEbf1 and shEbf1-2-3 
• Ebf2-flag transfected COS cells and treated with shEbf2 and shEbf1-2-3 
• Ebf3-flag transfected COS cells and treated with shEbf3 and shEbf1-2-3 
 
Moreover, immunolabelling for flag and GFP, expressed by the overexpressing and 
shEbf plasmids, respectively, confirmed a downregulation of the EBF proteins in 
cells co-expressing the specific shEbfs (Figure 4.4, 4; A-J, circles). A number of cells 
espressing the Ebf-flag plasmids, not co-tranfected with shEbfs, showed anyway a 
decreased flag signal, raising questions about the specificity and efficiency of the 
RNAi plasmids. This discrepancy could be due by a different efficiency rate of 
tranfection as the two plasmids were transfected at different time point. However, the 
western blot results undoubtely confirmed that the Ebf-flag plasmids lead to a 
specific expression of the EBF proteins in COS cells. Furthermore, EBF proteins can 
be effectively and specifically silenced by shEbf plasmids.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
154 
 
 
Figure 4.4 Analysis of the function and specificity of overexpressing and 
silencing Ebf plasmids 
 
1-3: Western blot analysis of EBF protein expression in transfected COS cells with 
different combination of Ebfs-flag and shEbfs plasmids (See Chapter 4.3.1 for 
details).  
4: Imunnohistochemistry for flag (Ebf-flag plasmids) and GFP (shEbf plasmids) 
shows downregulation in the expression of EBF in COS cells co-transfected with 
Ebf1-flag (A-D), Ebf2-flag (E-G), Ebf3-flag (H-L) and the specific shEbf (cells in the 
circles double tranfected with shEbf and Ebf-flag show a reduction of the intensity of 
the flag signal). 
 
α-tub: alpha-tubulin, DAPI: 4'-6-Diamidino-2-phenylindole, GFP: green fluorescent 
protein, kDa: kilo-Dalton 
Scale bar: (A-L) 10 µm 
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4.3.2 Overexpression and downregulation of EBF proteins affect the 
migration of GN11 cells in vitro 
 
GN11 cells, a cell line of immortalised immature neurons with high migratory 
behavior (Radovick et al., 1991), were found to express Ebf1 and Ebf3 but not Ebf2 
(Figure 4.5, B). For this reason, they were used as a model to study the role of Ebf 
genes in migration. These cells, maintained in culture, were transfected with the Ebf-
flag and shEbf plasmids, and analysed in a chemotactic assay using the Boyden 
chamber (Figure 4.5, A).  
Firstly, GN11 cells were treated with Ebf1, Ebf2 and Ebf3-flag to study the effect 
of the overexpression of these genes on cell chemotaxis. Cells were transfected with 
Ebf-flag plasmids and cultured 48 h prior the Boyden chamber. GN11 cells 
transfected with Ebf1, Ebf2 and Ebf3-flag migrated more towards the 
chemoattractant (1% FBS) compared to the control cells (Mock) (Figure 4.5, C: a 
compared to b; c, Mock 609±36, Ebf1-flag 1522±30, Ebf2-flag 1585±24, Ebf3-flag 
1747±48; n=3; p<0.001).  
As EBFs overexpression caused an increase in the migration of GN11 cells, I have 
subsequently analysed the effects of their downregulation on cell chemotaxis. Cells 
were transfected with shEbf plasmids and cultured for 72 h before the chemotactic 
assay. GN11 cells treated with shEbf1, shEbf3 and shEbf1-2-3 showed a decreased 
migration compared to the Mock and shEbf2 treated GN11 (Figure 4.5, D: a 
compared to b; c, Mock 1273±58, shEbf2 1200±60, shEbf1 544±59, shEbf3 603±80, 
shEbf1-2-3 500±36; n=3; p<0.01). Interestingly, the migration of shEbf1-2-3 
transfected cells was more affected compared to GN11 cells treated with a single 
shEbf.  
Moreover, I have tested whether the defective migration of shEbf treated GN11 
cells could be rescued by the transfection with plasmids overexpressing the Ebf 
genes (Ebf-flag). Cells were transfected with shEbf1, shEbf3 and shEbf1-3, cultured 
for 72 h and transfected with Ebf1/3-flag plasmids. Boyden chamber was performed 
after 48 h the second transfection. However, the flag constructs used in the following 
experiment were not shRNA resistant. In order to overcome a possible 
downregulation of the flag by the RNAi, a greater quantity of flag plasmids was 
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transfected (according to manufacture’s instruction) in order to saturate the shEbf 
plasmids.  
The defective migration of GN11 cells caused by the Ebfs downregulation was 
successfully rescued by their later overexpression (Figure 4.6, a compared to b; c, 
Mock 1273±58, shEbf1 544±59 and shEbf1+Ebf1-flag 1740±66, shEbf3 603±80 and 
shEbf3+Ebf3-flag 1740±66, shEbf1-3 500±36 and shEbf1-3+Ebf1-flag 1679±76, or 
+Ebf3-flag 1594±88, or +Ebf1/3-flag 1902±43; n=3; p<0.001). Surprisingly, Ebf3-
flag rescued the migration of shEbf1 treated cells (Figure 4.6, D; c: shEbf1 544±59, 
shEbf1+Ebf3-flag 1501±74, n=3; p<0.001) and Ebf1-flag of shEbf3 treated cells 
(Figure 4.6, D; c: shEbf3 603±80, shEbf3+Ebf1-flag 1496±63, n=3; p<0.001). 
In conclusion, these results suggest that Ebf factors are strongly involved in 
neuron migration and compensate for each other’s the function in vitro.  
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Figure 4.5 Ebfs-flag and shEbfs affect the migration of GN11 cells in vitro 
A: Schema of the Boyden chamber. 
B: Agarose gel shows the expression of Ebf1 and Ebf3 in GN11 cells. 
C: a and b show GN11 cells bound to the porous membrane after the chemotactic 
assay. Fewer cells are visible in the Mock sample (a) compared to the Ebf-flag (b). 
(c) Chart shows the effect on the migration of GN11 cells towards the 
chemoattractant FBS when treated with Ebfs overexpression plasmids. GN11 cells do 
not migrate towards pure DMEM (left side of the chart). 
D: a and b show GN11 cells bound to the porous membrane after the chemotactic 
assay. More cells are visible in the Mock sample (a) compared to the shEbf (b). (c) 
Chart shows the effect on the migration of GN11 cells when treated with Ebfs 
silencing plasmids. GN11 cells do not migrate towards pure DMEM (left side of the 
chart). 
 
DMEM: Dulbecco modified eagle’s medium, FBS: fetal bovine serum. 
 
Scale bar (C: a, b; D: a, b) 25 µm 
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Figure 4.6 The migration of GN11 cells treated with shEbf1-3 is rescued 
when transfected with Ebf1/3-flag plasmids 
A-C: GN11 cells bound to the porous membrane after the chemotactic assay. More 
cells are visible in the Mock sample (a) compared to the Ebf-flag (b). However, the 
migration is rescued after transfection with Ebf-flag plasmids.  
D: Chart shows the effect on the migration of GN11 cells towards the 
chemoattractant FBS when treated with shEbfs and Ebf-flag plasmids. GN11 cells do 
not migrate towards pure DMEM (left side of the chart). 
 
DMEM: Dulbecco modified eagle’s medium, FBS: fetal bovine serum. 
 
Scale bar (A-C) 25 µm 
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4.3.3 Cortical hem and septum targeted in utero electroporation of 
shEbf 
 
Preliminary in vitro experiments on GN11 cells in vitro have shown that EBFs 
can strongly affect cell migration and compensate each other loss of function. As 
they are expressed in overlapping pallial territories (Chapter 4.2), I analysed the 
effect of a selective downregulation of these factors specifically in CR cells. 
Embryos at E10.5 were electroporated in utero in the CH of left telencephalic 
hemispheres with different combinations of shEbf as follows: shEbf1-2, shEbf2-3 and 
shEbf1-2-3. Electroporated embryos were subsequently collected at E13.5, and CR 
cell commitment was analysed by in situ hybridisation. Expression of Reelin mRNA, 
Wnt3a and Foxg1 in the electroporated telencephalic side (Ep-side) was compared 
with the non-electroporated side (wt-side). A GFP in situ probe visualised the site of 
the electroporation. shEbf1-2 were electroporated in the CH (Figure 4.7, A; GFP), 
but changes were not detected in Reelin mRNA (Figure 4.7, A; Ep-side compared to 
wt-side, arrow), Wnt3a and Foxg1 expression (Figure 4.7, D; Ep-side compared to 
wt-side, arrow). shEbf2-3 were electroporated in the CH and neocortex (Figure 4.7, 
B; GFP), but no significant changes were found in Reelin mRNA (Figure 4.7, B; Ep-
side compared to wt-side, arrow), Wnt3a and Foxg1 expression (Figure 4.7, E; Ep-
side compared to wt-side, arrow). To test whether a downregulation of all the three 
Ebfs was required to give a defective phenotype, shEbf1-2-3 were electroporated in 
the CH (Figure 4.7, C; GFP). shEbf1-2-3 brains did not show changes in Reelin 
mRNA (Figure 4.7, C; Ep-side compared to wt-side, arrow), Wnt3a and Foxg1 
expression (Figure 4.7, F; Ep-side compared to wt-side, arrow). Moreover, CR cell 
migration was followed in shEbf3 electroporated brains. Embryos were 
electroporated at E10.5 with shEbf3 in the CH and collected at E13.5, when CR cell 
migration was almost completed. Calretinin antibody was used to label CR cells and 
GFP to discriminate electroporated cells. shEbf3 was electroporated in the CH and 
GFP+ migrating cells were visible in the PPL. Electroporated cells were also positive 
for Calr, a marker for CR cells (Figure 4.8, C; GFP+/Calr+, arrow), and localised in 
the CH and PPL (Figure 4.8, A-C) as in N-Ep (non-electroporated) brains (Figure 
4.8, D-F; arrow points to Calr+). In conclusion, the downregulation of Ebfs in the CH 
did not affect the commitment and migration of CR cells. Most likely the lack of 
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phenotype was due to an insufficient downregulation of the endogenous gene 
expression by the shRNA in vivo as well as the increased complexity of the 
biological system when compared with cells cultured in vitro. 
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Figure 4.7 CR cell fate in utero electroporated brains 
 
In situ hybridisation; E13.5 forebrain, coronal sections, 40 µm. 
In utero electroporation was performed at E10.5 
Dotted lines separate Ep-side from wt-side. 
 
A, D: Double-colour in situ hibridisation on GFP/Reelin mRNA (A) and 
Wnt3a/Foxg1 (D) shEbf1-2 electroporated embryos. 
B, E: Double-colour in situ hibridisation on GFP/Reelin mRNA (B) and 
Wnt3a/Foxg1 (E)shEbf2-3 electroporated embryos. 
C, F: Double-colour in situ hibridisation on GFP/Reelin mRNA (C) and 
Wnt3a/Foxg1 (F) shEbf1-2 electroporated embryos. 
 
CH: cortical hem, Ep-side: electroporated side, Foxg1: forkhead box G1, MZ: 
marginal zone NCx: neocortex, PPL: preplate, Wnt3a: wingless type 3a, wt-side: 
wild type side. 
 
Scale bar: 100 µm 
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Figure 4.8 CR cell migration is not affected in shEbf3 in utero electroporated 
brains 
 
Immunofluorescence; E13.5 forebrain, coronal section, 20 µm. 
In utero electroporation was performed at E10.5 
 
A, C: shEbf3 electroporation was targeted in the CH (A, GFP+ cells). Calretinin+ (B) 
and electroporated cells (GFP+, C) are migrating out the CH to cover the PPL as 
expected. 
D, F: Non electroporated brain samples show wt migration of Calr+. 
 
Calr: calretinin, CH: cortical hem, GFP: green fluorescent protein, N-Ep: non 
electroporated, PPL: preplate. 
 
Scale bar: 100 µm 
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4.4  DISCUSSION 
 
4.4.1 Ebf1 and Ebf3 transcription factors are expressed in overlapping 
pallial territories and compensate the Ebf2 loss of function 
 
COE genes encode phylogenetically conserved HLH transcription factors and are 
implicated in various aspects of neural development, such as neuronal differentiation 
(Dubois et al. 1998; Pozzoli et al. 2001), migration (Garcia-Dominguez et al. 2003; 
Garel et al. 2000) and axon fasciculation and guidance (Garel et al. 1999; 2002). 
Previous studies have shown that these factors are expressed in overlapping 
territories in different areas of the developing nervous system, including the olfactory 
epithelium, forebrain and cerebellum, playing redundant as well as specific functions 
(Garel et al. 1997; Croci et al. 2006). For example, Ebf1 and Ebf3 play redundant 
roles in the olfactory epithelium, whereas Ebf2 is necessary for GnRH neuron 
migration and its loss of function leads to apoptosis of these cells (Corradi et al. 
2003). In the cerebellum, all Ebf genes are expressed in Purkinje cells. Ebf1 and Ebf3 
are expressed among the entire cell population, whereas Ebf2, which is specifically 
expressed in a subpopulation, is indispensable for their migration and its loss of 
function leads to dramatic defects in the topography of the cerebellar cortex (Croci et 
al. 2006). Although Ebf1-/- and Ebf2-/- mice are available, Ebf3-/- mice are not viable 
(S. Garel and G. Consalez, unpublished), making it difficult to understand its role 
compared to other members of the COE family. Despite the work of Garel and 
colleagues (1997), Ebfs were never extensively studied during forebrain 
development. I have, for the first time, specifically characterised Ebf2 expression and 
the effects of its loss of function during pallial development. Moreover, in Chapter 4, 
I have shown that Ebf1, Ebf2 and Ebf3 are also expressed in the same cortical 
territories; in particular, within sites of origin and migration of CR cells. These 
results link the Ebf transcription factors to CR cells, and suggest that the lack of 
gross pallial defects in Ebf2-/- mice may be due to a common function of Ebf genes in 
regulating the development of CR cells arising from the CH and septum. 
Specifically, Ebfs are expressed in the CH, PPL/MZ and septum of the pallium at 
early developmental stages and are subsequently downregulated in these areas at 
E15.5 (Chapter 4). Interestingly, Ebf2 and Ebf3 are strongly expressed in the CH and 
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PPL/MZ, whereas Ebf1 is weakly detected in these areas. This suggests two different 
scenarios responsible for this phenomenon. Firstly, Ebf2 and Ebf3 may regulate the 
level of Ebf1 expression as they are already co-expressed in the same territory. 
Secondly, Ebf1 may be expressed exclusively within a subpopulation of CH derived 
CR cells, as is the case in the cerebellum. In the septum, a similar trend was 
observed. Ebf3 was strongly expressed dorso-ventrally, but Ebf1 was only expressed 
weakly and Ebf2 was confined dorsally. The expression of Ebf1 and Ebf3 in Ebf2-/- 
mice was unchanged in the CH and PPL/MZ, whereas it was downregulated in the 
septum. Previously, in Xenopus, Pozzoli and colleagues (2001) have shown that Ebf2 
is activated during Notch signalling and is involved in maintaining high neural 
potential of precursor cells, but at the same time promotes the commitment into 
neuronal fate. In this model, Ebf3 acts downstream of Ebf2, stimulating the 
development of specific cell subtypes.  
Moreover, Ebf3 was the only member of the COE transcription factor family 
expressed in the PSPB. According to recent findings of Griveau and colleagues, 
ablation of a CR cell subpopulation cause a redistribution of CR cells from other 
sources as a compensatory mechanisms. The expansion of the Ebf3 domain in the 
PSPB of Ebf2-/- mice suggests therefore a non cell-autonomous compensatory 
mechanism of the migratory defect seen in the mutants. 
In conclusion, these data suggest that Ebf2 may be involved in regulating the 
expression of Ebf1 and Ebf3 in the septum, affecting CR cell migration from this 
region, while Ebf1 and Ebf3 compensate its loss from the CH, and Ebf3 from the 
PSPB.  
 
4.4.2 Alternative mechanisms are involved in the compensation of 
Ebf2-/- mouse phenotype 
 
Cajal-Retzius cells are a complex, transient population organized into 
subpopulations specified by different domains, such as the CH, septum and PSPB 
(Bielle et al. 2005, Griveau et al. 2010). The combinations of these different CR cell 
subtypes populate distinct regions of the pallium rostro-caudally. Recently, Griveau 
and colleagues (2010) have shown that the genetic ablation of the septum leads to a 
redistribution of PSPB and CH-derived CR cells along with changes in early 
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patterning events and cell division and differentiation. However, alterations to cell 
division and differentiation do not lead to major cortical defects (Griveau et al. 
2010). These findings could suggest a possible redistribution along the rostro-caudal 
axis of CR cell subpopulations in Ebf2-/- mice, as well as increased production of CR 
cells from other sources. In fact, Ebf2-/- mice have shown a decreased number in 
Reelin and Calr positive cells in the MZ of caudo-medial sections and an increase of 
Reelin and Calr cells in the CH, suggesting a delay in the migration of CR cells from 
this region. Conversely, Dbx1 expression was diminished in the septum, together 
with Ebf1 and Ebf3, suggesting that Ebf2 may be an upstream factor regulating its 
expression and function in this area as well as the CR cell commitment and migration 
(Pozzoli et al. 2001). Moreover, the number of mitotic cells (PH3 positive, data not 
shown) was decreased in the pallial VZ at E11.5, whereas it was increased in the CH 
at E12.5. According to recent findings of Griveau and colleagues, these data suggest 
compensatory mechanisms, which induce a precocious generation of postmitotic 
neurons to populate the early preplate (Kowalczyk et al. 2009) and a possible 
redistribution of the other CR subpopulations, as suggested by the expansion of the 
Dbx1 and Ebf3 domains in the PSPB of Ebf2-/- mice. Furthermore, these defects 
correlate with changes in the size and positioning of cortical areas at postnatal stages 
without affecting signaling centers or cortical lamination (Griveau et al. 2010; 
Yoshida et al. 2006), which could also be the case in Ebf2-/- mice. In fact, the 
reduction of cortical thickness in these mutants may mask arealisation defects, which 
were not examined in this thesis. Thus, Ebf2 loss of function may be recouped by 
two different mechanisms, a redundant expression of Ebf1 and Ebf3 in the CH as 
well as CR cell redistribution, possibly from the PSPB.  
 
4.4.3 Ebf factors influence the migration of immortalized immature 
neurons in vitro 
 
Ebf factors are strictly connected with cell migration in different species. Ebf2 is 
involved in the migration of a subpopulation of Purkinje cells in the cerebellum and 
GnRH neurons from the olfactory epithelium to the hypothalamus (Corradi et al. 
2003; Croci et al. 2006). In Chapter 3, I have shown that Ebf2-/- mice displayed a 
transitory migration defect in CR cells restored later by compensatory mechanisms. 
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Therefore, I have tested whether the overexpression and silencing of one or a 
combination of more Ebfs could affect the migration of neurons, with a specific 
focus on the activity of migration. As a model, I have used GN11 cells, which are 
neurons derived from immature, immortalised GnRH cells. RT-PCR and micro-array 
analysis have confirmed that these cells express Ebf1 and Ebf3, but not Ebf2. (A. 
Cariboni, unpublished). Overexpression of Ebf1 and Ebf3 genes in GN11 cells lead 
to increased migration in comparison with control mock-transfected cells (Chapter 
4). Interestingly, Ebf2 overexpression caused an increase in cell migration, 
suggesting that this gene, even when not expressed, can trigger migratory 
mechanisms most likely acting through the same signal pathway as for Ebf1 and 
Ebf3. 
On the other hand, downregulation of Ebf1 and Ebf3 caused a significant decrease 
in cell migration compared to the non-treated control cells. Downregulation of both 
genes caused a stronger phenotype, suggesting that the function of Ebf genes may be 
dose-dependent. As expected, downregulation of Ebf2 did not lead to significant 
changes in GN11 cell behavior. Moreover, transfection of Ebf1 and Ebf3 in shRNA-
treated GN11 cells were able to rescue the defective migration of these cells. 
Interestingly, Ebf1 was able to rescue the phenotype caused by shEbf3 and vice 
versa. Thus, this suggests that Ebfs can play a redundant function and complement 
each other. 
Taken together this data confirm that Ebf factors are involved in neuron 
migration. They may play redundant functions and, most likely, affect the migration 
of other neuron types expressing Ebfs, in particular, CR cells. 
 
4.4.4 Target in vivo downregulation of Ebfs expression in CR cells by 
in utero electroporation 
 
Single mutants are available for Ebf1 and Ebf2. However, Ebf3 single mutants are 
not yet available. Alternatively, in utero electroporation, performed in collaboration 
with Dr T. Shimogori (Riken BSI, Tokyo), was used to specifically downregulate the 
expression of Ebf genes in the CH where they are expressed at high levels. The 
electroporation was performed at E10.5 and the electroporated embryos analysed at 
E13.5. Cell commitment and migration was studied in successfully electroporated 
172 
 
cells. Changes were not detected in any of the electroporated brains for any of the 
different combinations of shRNA used. Technical limitations render these 
experiments extremely challenging. Firstly, to target the CH and septum in early 
embryos was extremely difficult because of the size and positions of the anatomical 
areas. Moreover, the viability of the electroporated embryos was very low, especially 
when two or more shEbfs were combined together, suggesting possible toxic effects 
of the plasmids. On the other hand, the lack of phenotype was most likely due to an 
insufficient downregulation of the endogenous gene expression by the shRNA in vivo 
as well as the increased complexity of the biological system when compared with 
cells cultured in vitro. 
 
4.4.5 Conclusions and Future experiments 
 
The present thesis provides several pieces of evidence that Ebf factors may play 
an important role in the development of CR cells. However, different hypothesis 
should be still tested to further complete my work. 
First, I have shown that Ebf factors strongly affect the migration and compensate 
each other’s functions in GN11 neurons in vitro. However, due to technical 
limitations the experiments were not yet reproducible specifically in CR cells. For 
this reason, I am currently pursuing a different approach to target the expression of 
EBF proteins in CR cells in collaboration with Dr Eikcholt (King’s College London). 
This approach consists of dissociating cells from murine CH at E11.5 and, after 
transfection by electroporation (Lonza) with overexpression or silencing Ebf 
plasmids, tests their ability of migration in vitro by stripe assays. Stripe assays test 
the ability of cells to migrate on a coverslip coated with various protein combinations 
such as laminin or CR cell chemoattractants, for example, SDF-1. 
Second, Ebf2-/- mice displayed changes in the expression of different genes in the 
CH, PSPB, neocortex (PPL/MZ) and septum. However, these results were confirmed 
only by in situ hybridization experiments. A specific microarray analysis on Ebf2+ 
cells may clarify the targets of Ebf2 transcription factor, which are still mostly 
unknown. In particular, I would cross breed the Ebf2-/- mice with Ebf2GFPiCre/R26R-YFP 
line, specifically isolate the YFP expressing cells and compare them with YFP+ cells 
from the pure Ebf2GFPiCre/R26R-YFP line. This strategy will permit to follow the 
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commitment and migration of Ebf2 expressing cells in the mutant and wt 
background, even after the downregulation of the endogenous gene.  
Moreover, several evidences in the Ebf2-/- mice showed a possible redistribution 
of CR cells populations in the cortex, possibly from the PSPB. To confirm this 
hypothesis, it would be useful to cross Ebf2-/- mice with the transgenic Dbx1β-gal line 
(Bielle et al. 2005) and follow the fate of Dbx1+ cells compared to Dbx1+ cells in the 
wt background. Calretinin antibody would be used to distinguish PSPB-Dbx1 and 
septum-Dbx1 derived CR cell subpopulations. 
Finally, most of the information on the functions of COE genes comes from the 
analysis of Ebf1 and Ebf2 mutants. It is known that COE members control neuronal 
commitment and cell migration during CNS development, playing redundant as well 
as specific functions, but little is still known about Ebf3 transcription factor. I have 
shown that Ebf factors are expressed in sites of origin of CR cells. However, the 
analysis of Ebf1 (Garel et al. 1999) and Ebf2 mutants did not reveal a specific role in 
the development of CR cells. The creation and phenotypic analysis of conditional 
Ebf3-/- mice, as Ebf3-/- mice are reported to be embryonically lethal, may elucidate an 
unique role of this factor in the development of CR cells. 
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CONCLUDING REMARKS 
GENETIC NETWORKS AND REDUNDANCY DEFINE 
THE COMPLEXITY OF BIOLOGICAL SYSTEMS 
 
 
 
 
 
 
Genetic redundancy is an amazing property of genomes and has only recently 
become evident as a result of negative knockout experiments. In fact, knockout 
strategies have demonstrated that the function of many genes cannot be studied by 
simply disrupting them in model organisms because the inactivation of these genes 
does not lead to any phenotypic effects. For living systems, the phenomenon of 
genetic redundancy seems common (Borger, 2008). Genetic redundancy involves 
two or more genes that can perform overlapping functions (Tautz, 1992; Nowak et 
al. 1997), but recent findings suggest that this is not always the case. In the following 
paragraph I will present two theories explaining the genetic redundancy and its 
effects. 
Most common ideas still follow the Darwin theories on gene evolution. Susumo 
Ohno writes in his book “Evolution by Gene Duplication”, that duplications of genes 
provide redundancies, which then accumulate mutations and adopt novel biological 
functions. Duplicates transforming into improved, novel genes are then favored by 
natural selection as they have an advantage over other genes. Meanwhile, the genetic 
redundancy will protect old functions, reducing the lethality of mutations. He also 
provides an explanation for the knockouts without phenotype: if genes duplicate 
fairly often, then it is expected to find redundancy in most genomes, because, 
according to natural selection, duplicates provide an organism with “back-up” genes 
(Ohno, 1970). However, in 2000, Wagner demonstrated that genes considered not 
essential are not more likely to have duplicates than other “essential” genes that 
cause a phenotype when they are knocked out. Wagner concluded that the no-
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phenotype effect cannot be caused exclusively by gene duplication and redundancy, 
but concomitant with interactions between unrelated genes (Wagner, 2000). The 
molecular biologist Peter Borger suggests that no-phenotype knockouts are explained 
if we take into account the non-linearity of biochemical systems. He argues that 
biological systems do not work like linear causality, where A causes B causes C 
causes D causes E. Biological systems are, instead, designed as a complex networks. 
He proposes instead a “simple non-linear biological system with nodes” where A 
may cause B, but A also causes D independent of B and C. Thus, if A fails to make 
the link with D, there are still B and C to make the connection. This theory gives the 
idea that not only gene duplication is important to maintain the stability of a living 
organism, but also the cross-talk between different genes, which could potentially 
give rise to an organization of genetic networks. Thus, genetic networks stabilize the 
complex regulatory mechanisms of living systems. They control homeostasis, 
regulate the maintenance of genomes and provide regulatory feedback on gene 
expression (Borger, 2008).  
In conclusion, if we consider complex biological systems such as mammals, it is 
most likely then these two mechanisms may coexist and cooperate together. Mario 
Cappecchi, a pioneer in the development of knockout technology, once said: “I don’t 
believe that there is a single mouse (knockout) that does not have a phenotype. We 
just aren’t asking the right questions.” (Quoted from H. Pearson, 2002), suggesting 
that in biology there is far more behind the expression and function of one simple 
gene. 
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